{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:26:54Z","timestamp":1791318414697,"version":"4.3.1"},"reference-count":998,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1124\/pr.115.011247","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T03:03:55Z","timestamp":1450235035000},"page":"76-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":316,"title":["Pharmacology of Heparin and Related Drugs"],"prefix":"10.1016","volume":"68","author":[{"given":"Barbara","family":"Mulloy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hogwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Lever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive P.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pr.115.011247_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0032-1301410","article-title":"Tissue factor pathway inhibitor: new insights into an old inhibitor","volume":"38","author":"Adams","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pr.115.011247_bib2","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.3390\/v4123785","article-title":"Diversity in glycosaminoglycan binding amongst hMPV G protein lineages","volume":"4","author":"Adamson","year":"2012","journal-title":"Viruses"},{"key":"10.1124\/pr.115.011247_bib3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.thromres.2015.02.001","article-title":"Duration of anticoagulation after venous thromboembolism in real world clinical practice","volume":"135","author":"Ageno","year":"2015","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11239-007-0103-z","article-title":"Treatment of DVT: how long is enough and how do you predict recurrence","volume":"25","author":"Agnelli","year":"2008","journal-title":"J Thromb Thrombolysis"},{"key":"10.1124\/pr.115.011247_bib956","doi-asserted-by":"crossref","unstructured":"Agnelli G, Buller HR, Cohen A, Gallus AS, Lee TC, Park R, Raskob GE, Weitz JI, Yamabe T (2015) Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial. Epub ahead of print 2015 Sep 26. doi: 10.1111\/jth.13153","DOI":"10.1111\/jth.13153"},{"key":"10.1124\/pr.115.011247_bib5","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1039\/C4MB00274A","article-title":"Comparative study of Plasmodium falciparum erythrocyte membrane protein 1-DBL\u03b1 domain variants with respect to antigenic variations and docking interaction analysis with glycosaminoglycans","volume":"10","author":"Agrawal","year":"2014","journal-title":"Mol Biosyst"},{"key":"10.1124\/pr.115.011247_bib6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/ajrccm\/145.3.566","article-title":"Effects of inhaled heparin on immunologic and nonimmunologic bronchoconstrictor responses in sheep","volume":"145","author":"Ahmed","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/pr.115.011247_bib7","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1164\/ajrccm.155.6.9196085","article-title":"Inhibition of antigen-induced acute bronchoconstriction, airway hyperresponsiveness, and mast cell degranulation by a nonanticoagulant heparin: comparison with a low molecular weight heparin","volume":"155","author":"Ahmed","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/pr.115.011247_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJM199307083290204","article-title":"Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin","volume":"329","author":"Ahmed","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.115.011247_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.pupt.2012.10.004","article-title":"Effect of oral and intravenous heparin tetrasaccharide on allergic airway responses: critical role of N-sulfation","volume":"26","author":"Ahmed","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/pr.115.011247_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1465-9921-13-6","article-title":"Inhibition of allergic airway responses by heparin derived oligosaccharides: identification of a tetrasaccharide sequence","volume":"13","author":"Ahmed","year":"2012","journal-title":"Respir Res"},{"key":"10.1124\/pr.115.011247_bib11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/jappl.1994.76.2.893","article-title":"Heparin prevents antigen-induced airway hyperresponsiveness: interference with IP3-mediated mast cell degranulation?","volume":"76","author":"Ahmed","year":"1994","journal-title":"J Appl Physiol (1985)"},{"key":"10.1124\/pr.115.011247_bib12","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1021\/ac201498a","article-title":"Competitive inhibition of heparinase by persulfonated glycosaminoglycans: a tool to detect heparin contamination","volume":"83","author":"Aich","year":"2011","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib13","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1111\/j.1742-4658.2009.07402.x","article-title":"Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry","volume":"276","author":"Akhtar","year":"2009","journal-title":"FEBS J"},{"key":"10.1124\/pr.115.011247_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006652.pub4","article-title":"Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer","volume":"6","author":"Akl","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pr.115.011247_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006652.pub4","article-title":"Parenteral anticoagulation in ambulatory patients with cancer","volume":"12","author":"Akl","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pr.115.011247_bib16","article-title":"Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation","volume":"3","author":"Akl","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pr.115.011247_bib17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-642-23056-1_10","article-title":"Adverse effects of heparin","volume":"207","author":"Alban","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pr.115.011247_bib18","article-title":"Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)","volume":"5","author":"Alikhan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pr.115.011247_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3892\/or.3.1.219","article-title":"Antimetastatic effects associated with anticoagulant properties of heparin and chemically modified heparin species in a mouse mammary tumor model","volume":"3","author":"Alonso","year":"1996","journal-title":"Oncol Rep"},{"key":"10.1124\/pr.115.011247_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1055\/s-2007-991531","article-title":"The role of tissue factor pathway inhibitor in tumor growth and metastasis","volume":"33","author":"Amirkhosravi","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pr.115.011247_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0049-3848(76)90105-5","article-title":"Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration","volume":"9","author":"Andersson","year":"1976","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib22","article-title":"Heparin versus placebo for non-ST elevation acute coronary syndromes","volume":"6","author":"Andrade-Castellanos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pr.115.011247_bib23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/glycob\/cwi091","article-title":"Dynamic properties of biologically active synthetic heparin-like hexasaccharides","volume":"15","author":"Angulo","year":"2005","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/cbic.200300696","article-title":"The activation of fibroblast growth factors (FGFs) by glycosaminoglycans: influence of the sulfation pattern on the biological activity of FGF-1","volume":"5","author":"Angulo","year":"2004","journal-title":"ChemBioChem"},{"key":"10.1124\/pr.115.011247_bib25","first-page":"386","article-title":"Heparin inhibits allergen-induced airway response in asthmatics - results of a double-blind placebo-controlled, crossover study","volume":"95","author":"Antczak","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/pr.115.011247_bib26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1160\/TH09-11-0761","article-title":"Heparins from porcine and bovine intestinal mucosa: Are they similar drugs?","volume":"103","author":"Aquino","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib27","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/jnr.22393","article-title":"Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer\u2019s disease and related disorders: amyloidogenesis and therapeutic strategies--a review","volume":"88","author":"Ariga","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.115.011247_bib28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.thromres.2012.12.005","article-title":"Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness","volume":"131","author":"Arnold","year":"2013","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib29","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.1161\/CIRCULATIONAHA.105.603100","article-title":"Anticoagulants and transaminase elevation","volume":"113","author":"Arora","year":"2006","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011247_bib30","doi-asserted-by":"crossref","first-page":"17394","DOI":"10.1021\/ja907358k","article-title":"Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies","volume":"131","author":"Arungundram","year":"2009","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.115.011247_bib31","series-title":"Heparin","first-page":"19","article-title":"Crystalline structure of heparin","author":"Atkins","year":"1975"},{"key":"10.1124\/pr.115.011247_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1124\/pr.115.011247_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbagen.2008.10.008","article-title":"Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets","volume":"1790","author":"Bachelet","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.115.011247_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4037\/ajcc1996.5.1.42","article-title":"Effectiveness of a jet injection system in administering morphine and heparin to healthy adults","volume":"5","author":"Baer","year":"1996","journal-title":"Am J Crit Care"},{"key":"10.1124\/pr.115.011247_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2141.2005.05953.x","article-title":"Guidelines on the use and monitoring of heparin","volume":"133","author":"Baglin","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1124\/pr.115.011247_bib36","doi-asserted-by":"crossref","first-page":"11079","DOI":"10.1073\/pnas.162232399","article-title":"Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism","volume":"99","author":"Baglin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/jamp.2009.0745","article-title":"Inhalable lactose-based dry powder formulations of low molecular weight heparin","volume":"23","author":"Bai","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1124\/pr.115.011247_bib38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ab.2009.03.009","article-title":"Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products","volume":"388","author":"Bairstow","year":"2009","journal-title":"Anal Biochem"},{"key":"10.1124\/pr.115.011247_bib39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0037-1616518","article-title":"Structure and biology of tissue factor pathway inhibitor","volume":"86","author":"Bajaj","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jmr.2250","article-title":"Mapping of heparin\/heparan sulfate binding sites on \u03b1v\u03b23 integrin by molecular docking","volume":"26","author":"Ballut","year":"2013","journal-title":"J Mol Recognit"},{"key":"10.1124\/pr.115.011247_bib41","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/glycob\/10.7.715","article-title":"The spacing of S-domains on HS glycosaminoglycans determines whether the chain is a substrate for intracellular heparanases","volume":"10","author":"Bame","year":"2000","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib42","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1182\/blood.V70.2.551.551","article-title":"Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species","volume":"70","author":"Bar-Ner","year":"1987","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2249.1997.4541471.x","article-title":"Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast cell-dependent cutaneous inflammation","volume":"110","author":"Baram","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1124\/pr.115.011247_bib44","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1002\/term.368","article-title":"Microchannel-patterned and heparin micro-contact-printed biodegradable composite membranes for tissue-engineering applications","volume":"5","author":"Baran","year":"2011","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1124\/pr.115.011247_bib45","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1182\/blood.V96.4.1618","article-title":"Alopecia and dalteparin: a previously unreported association","volume":"96","author":"Barnes","year":"2000","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib46","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(60)92299-6","article-title":"Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial","volume":"1","author":"Barritt","year":"1960","journal-title":"Lancet"},{"key":"10.1124\/pr.115.011247_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-23056-1_1","article-title":"History of heparin","volume":"207","author":"Barrowcliffe","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pr.115.011247_bib48","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0038-1651034","article-title":"The effect of calcium chloride on anti-Xa activity of heparin and its molecular weight fractions","volume":"62","author":"Barrowcliffe","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib49","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1158\/1078-0432.CCR-05-2423","article-title":"A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors","volume":"12","author":"Basche","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"Suppl","key":"10.1124\/pr.115.011247_bib50","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"10.1124\/pr.115.011247_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1527-3466.2002.tb00081.x","article-title":"Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitors","volume":"20","author":"Bauer","year":"2002","journal-title":"Cardiovasc Drug Rev"},{"issue":"16","key":"10.1124\/pr.115.011247_bib1000","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/01.CIR.98.16.1610","article-title":"Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans","volume":"98","author":"Baughman","year":"1998","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011247_bib52","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/cbic.201000207","article-title":"Divergent heparin-induced fibrillation pathways of a prion amyloidogenic determinant","volume":"11","author":"Bazar","year":"2010","journal-title":"ChemBioChem"},{"key":"10.1124\/pr.115.011247_bib53","first-page":"268","article-title":"Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions","volume":"121","author":"Bazzoni","year":"1993","journal-title":"J Lab Clin Med"},{"key":"10.1124\/pr.115.011247_bib54","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1021\/ac3007494","article-title":"Identification of a novel structure in heparin generated by sequential oxidative-reductive treatment","volume":"84","author":"Beccati","year":"2012","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib55","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1096\/fj.12-216176","article-title":"Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis","volume":"27","author":"Bechara","year":"2013","journal-title":"FASEB J"},{"issue":"3Pt2","key":"10.1124\/pr.115.011247_bib1001","first-page":"H925","article-title":"Heparin-released superoxide dismutase inhibits post ischemic leukocyte adhesion to venular endotheilium","volume":"267","author":"Becker","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.011247_bib56","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jpba.2010.03.037","article-title":"An assessment of polydispersed species in unfractionated and low molecular weight heparins by diffusion ordered nuclear magnetic resonance spectroscopy method","volume":"53","author":"Bednarek","year":"2010","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pr.115.011247_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4614-0887-1_1","article-title":"The structural biology of the FGF19 subfamily","volume":"728","author":"Beenken","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pr.115.011247_bib58","doi-asserted-by":"crossref","first-page":"21100","DOI":"10.1074\/jbc.M700841200","article-title":"C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease","volume":"282","author":"Beinrohr","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib59","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3109\/0284186X.2014.934397","article-title":"Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis","volume":"53","author":"Ben-Aharon","year":"2014","journal-title":"Acta Oncol"},{"issue":"9","key":"10.1124\/pr.115.011247_bib957","first-page":"677","volume":"37","author":"Ben Salem","year":"2014","journal-title":"Drug-induced hyperkalemia"},{"key":"10.1124\/pr.115.011247_bib60","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1183\/09031936.02.00105202","article-title":"Effect of inhaled heparin on lung function and coagulation in healthy volunteers","volume":"19","author":"Bendstrup","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1124\/pr.115.011247_bib61","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00216-010-4121-x","article-title":"Analysis and characterization of heparin impurities","volume":"399","author":"Beni","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pr.115.011247_bib62","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.thromres.2014.09.033","article-title":"A case series of LMWH use in pregnancy: should trough anti-Xa levels guide dosing?","volume":"134","author":"Berresheim","year":"2014","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib63","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/bm049693s","article-title":"Molecular weight determination of heparin and dermatan sulfate by size exclusion chromatography with a triple detector array","volume":"6","author":"Bertini","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1124\/pr.115.011247_bib64","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/ejh.12179","article-title":"Fondaparinux-associated heparin-induced thrombocytopenia","volume":"91","author":"Bhatt","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1124\/pr.115.011247_bib65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2007-996063","article-title":"Heterogeneity of unfractionated heparins studied in connection with species, source, and production processes","volume":"23","author":"Bianchini","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pr.115.011247_bib66","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2133.1990.tb01457.x","article-title":"Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction","volume":"123","author":"Bircher","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1124\/pr.115.011247_bib67","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2133.1995.tb08684.x","article-title":"Delayed hypersensitivity to one low-molecular-weight heparin with tolerance of other low-molecular-weight heparins","volume":"132","author":"Bircher","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1124\/pr.115.011247_bib68","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1160\/TH09-02-0081","article-title":"Structural features of low-molecular-weight heparins affecting their affinity to antithrombin","volume":"102","author":"Bisio","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib69","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1021\/ja983319g","article-title":"Docking of glycosaminoglycans to heparin-binding proteins: validation for aFGF, bFGF, and antithrombin and application to IL-8","volume":"121","author":"Bitomsky","year":"1999","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.115.011247_bib70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00421226","article-title":"Mechanism of the anticoagulant action of heparin","volume":"48","author":"Bj\u00f6rk","year":"1982","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/pr.115.011247_bib71","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1089\/ten.tea.2008.0348","article-title":"In vivo recruitment of hematopoietic cells using stromal cell-derived factor 1 alpha-loaded heparinized three-dimensional collagen scaffolds","volume":"15","author":"Bladergroen","year":"2009","journal-title":"Tissue Eng Part A"},{"key":"10.1124\/pr.115.011247_bib72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nchembio.1696","article-title":"Structural basis for sialic acid-mediated self-recognition by complement factor H","volume":"11","author":"Blaum","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1124\/pr.115.011247_bib73","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1056\/NEJMoa0806450","article-title":"Outbreak of adverse reactions associated with contaminated heparin","volume":"359","author":"Blossom","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.115.011247_bib74","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-3148.2001.00340.x","article-title":"Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice?","volume":"11","author":"Boehlen","year":"2001","journal-title":"Transfus Med"},{"key":"10.1124\/pr.115.011247_bib75","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0536.1996.tb02293.x","article-title":"Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids","volume":"35","author":"Boehncke","year":"1996","journal-title":"Contact Dermat"},{"key":"10.1124\/pr.115.011247_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1743-422X-8-45","article-title":"Sequence similarity between the erythrocyte binding domain 1 of the Plasmodium vivax Duffy binding protein and the V3 loop of HIV-1 strain MN reveals binding residues for the Duffy Antigen Receptor for Chemokines","volume":"8","author":"Bolton","year":"2011","journal-title":"Virol J"},{"key":"10.1124\/pr.115.011247_bib77","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/1743-422X-8-523","article-title":"Sequence similarity between the erythrocyte binding domain of the Plasmodium vivax Duffy binding protein and the V3 loop of HIV-1 strain MN reveals a functional heparin binding motif involved in binding to the Duffy antigen receptor for chemokines","volume":"8","author":"Bolton","year":"2011","journal-title":"Virol J"},{"key":"10.1124\/pr.115.011247_bib78","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1042\/bj3260661","article-title":"Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells","volume":"326","author":"Bono","year":"1997","journal-title":"Biochem J"},{"issue":"Suppl 2","key":"10.1124\/pr.115.011247_bib79","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/S0049-3848(10)70017-7","article-title":"Antimetastatic activities of heparins and modified heparins. Experimental evidence","volume":"125","author":"Borsig","year":"2010","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib80","doi-asserted-by":"crossref","first-page":"14984","DOI":"10.1074\/jbc.M610560200","article-title":"Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitment","volume":"282","author":"Borsig","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib81","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.061615598","article-title":"Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis","volume":"98","author":"Borsig","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib82","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0022-5223(03)00813-4","article-title":"Life-threatening anaphylactic shock caused by porcine heparin intravenous infusion during mitral valve repair","volume":"126","author":"Bottio","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1124\/pr.115.011247_bib83","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/blood-2009-04-217240","article-title":"Anticoagulant and antithrombotic properties of platelet protease nexin-1","volume":"115","author":"Boulaftali","year":"2010","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib84","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2011-10-387464","article-title":"Emerging role of serpinE2\/protease nexin-1 in hemostasis and vascular biology","volume":"119","author":"Bouton","year":"2012","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib85","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1164\/ajrccm\/147.1.160","article-title":"Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects","volume":"147","author":"Bowler","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/pr.115.011247_bib86","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1055\/s-0038-1660139","article-title":"A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis","volume":"54","author":"Bratt","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib87","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tcb.2014.12.004","article-title":"BMP signalling: agony and antagony in the family","volume":"25","author":"Brazil","year":"2015","journal-title":"Trends Cell Biol"},{"key":"10.1124\/pr.115.011247_bib88","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1021\/ja311734d","article-title":"Mallard blue: a high-affinity selective heparin sensor that operates in highly competitive media","volume":"135","author":"Bromfield","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.115.011247_bib89","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.1039\/c3cs60278h","article-title":"Heparin sensing and binding - taking supramolecular chemistry towards clinical applications","volume":"42","author":"Bromfield","year":"2013","journal-title":"Chem Soc Rev"},{"key":"10.1124\/pr.115.011247_bib90","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.bpj.2013.02.051","article-title":"Cooperative heparin-mediated oligomerization of fibroblast growth factor-1 (FGF1) precedes recruitment of FGFR2 to ternary complexes","volume":"104","author":"Brown","year":"2013","journal-title":"Biophys J"},{"key":"10.1124\/pr.115.011247_bib91","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pupt.2006.04.004","article-title":"Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination","volume":"19","author":"Brown","year":"2006","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/pr.115.011247_bib92","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0705291","article-title":"Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro","volume":"139","author":"Brown","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib1003","doi-asserted-by":"crossref","first-page":"L1240","DOI":"10.1152\/ajplung.00206.2007","article-title":"Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis","volume":"293","author":"Broughton-Head","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/pr.115.011247_bib93","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.V71.2.335.335","article-title":"The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action","volume":"71","author":"Broze","year":"1988","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib94","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2222.1997.tb01193.x","article-title":"Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions","volume":"27","author":"Brunn\u00e9e","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1124\/pr.115.011247_bib95","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa035451","article-title":"Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism","volume":"349","author":"B\u00fcller","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.115.011247_bib96","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1101\/gad.12.12.1894","article-title":"Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase","volume":"12","author":"Bullock","year":"1998","journal-title":"Genes Dev"},{"key":"10.1124\/pr.115.011247_bib97","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1128\/AAC.02594-14","article-title":"Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures","volume":"58","author":"Cagno","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/pr.115.011247_bib98","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1021\/ac2016135","article-title":"Butterfly-shaped conjugated oligoelectrolyte\/graphene oxide integrated assay for light-up visual detection of heparin","volume":"83","author":"Cai","year":"2011","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib99","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cps.2009.05.013","article-title":"Airway management and smoke inhalation injury in the burn patient","volume":"36","author":"Cancio","year":"2009","journal-title":"Clin Plast Surg"},{"key":"10.1124\/pr.115.011247_bib100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0969-2126(00)00549-9","article-title":"Annexin V--heparin oligosaccharide complex suggests heparan sulfate--mediated assembly on cell surfaces","volume":"9","author":"Capila","year":"2001","journal-title":"Structure"},{"key":"10.1124\/pr.115.011247_bib101","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0014-5793(99)00245-8","article-title":"Interaction of heparin with annexin V","volume":"446","author":"Capila","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.115.011247_bib102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.ATV.9.1.21","article-title":"Molecular modeling of protein-glycosaminoglycan interactions","volume":"9","author":"Cardin","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.1124\/pr.115.011247_bib103","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1592\/phco.21.1.108.34436","article-title":"Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity","volume":"21","author":"Carlson","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1124\/pr.115.011247_bib104","series-title":"Heparin - A Century of Progress","first-page":"23","article-title":"Heparin biosynthesis","author":"Carlsson","year":"2012"},{"key":"10.1124\/pr.115.011247_bib105","doi-asserted-by":"crossref","first-page":"20008","DOI":"10.1074\/jbc.M801652200","article-title":"Heparin\/heparan sulfate biosynthesis: processive formation of N-sulfated domains","volume":"283","author":"Carlsson","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib106","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0049-3848(79)90097-5","article-title":"The anti-inflammatory action of heparin: heparin as an antagonist to histamine, bradykinin and prostaglandin E1","volume":"16","author":"Carr","year":"1979","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib107","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.thromres.2014.09.039","article-title":"Efficacy and safety of anticoagulant therapy for the treatment of acute cancer-associated thrombosis: a systematic review and meta-analysis","volume":"134","author":"Carrier","year":"2014","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib108","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1074\/jbc.M411606200","article-title":"Crystal structure of thrombin bound to heparin","volume":"280","author":"Carter","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib109","first-page":"135","article-title":"Correlation between structure, fat-clearing and anticoagulant properties of heparins and heparan sulphates","volume":"33","author":"Casu","year":"1983","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/pr.115.011247_bib110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0065-2318(01)57017-1","article-title":"Structure and biological interactions of heparin and heparan sulfate","volume":"57","author":"Casu","year":"2001","journal-title":"Adv Carbohydr Chem Biochem"},{"issue":"Suppl 3","key":"10.1124\/pr.115.011247_bib111","first-page":"17","article-title":"Structural characterization of low molecular weight heparins","volume":"25","author":"Casu","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pr.115.011247_bib112","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000175157","article-title":"Non-anticoagulant heparins and inhibition of cancer","volume":"36","author":"Casu","year":"2008","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1124\/pr.115.011247_bib113","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5082\/2\/1\/014102","article-title":"Combining electrospinning and fused deposition modeling for the fabrication of a hybrid vascular graft","volume":"2","author":"Centola","year":"2010","journal-title":"Biofabrication"},{"key":"10.1124\/pr.115.011247_bib114","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11239-014-1153-7","article-title":"A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal","volume":"40","author":"Chan","year":"2015","journal-title":"J Thromb Thrombolysis"},{"key":"10.1124\/pr.115.011247_bib115","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006774.pub2","article-title":"Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis","volume":"2","author":"Chande","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pr.115.011247_bib116","doi-asserted-by":"crossref","first-page":"44391","DOI":"10.1074\/jbc.M111.285361","article-title":"Two distinct sites in sonic Hedgehog combine for heparan sulfate interactions and cell signaling functions","volume":"286","author":"Chang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib117","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.arthro.2014.03.009","article-title":"Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trials","volume":"30","author":"Chapelle","year":"2014","journal-title":"Arthroscopy"},{"key":"10.1124\/pr.115.011247_bib118","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/cvr\/cvp097","article-title":"Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia\/reperfusion","volume":"83","author":"Chappell","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1124\/pr.115.011247_bib119","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1016\/j.bmc.2012.11.053","article-title":"Use of biosynthetic enzymes in heparin and heparan sulfate synthesis","volume":"21","author":"Chappell","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pr.115.011247_bib120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0021-9258(18)74257-9","article-title":"Studies on the chemistry of blood coagulation. VI. Studies on the action of heparin and other anticoagulants. The influence of protamine on the anticoagulant effect in vivo","volume":"122","author":"Chargaff","year":"1937","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib121","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1021\/bi0356552","article-title":"Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression","volume":"43","author":"Chen","year":"2004","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib122","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-642-23056-1_6","article-title":"Case study: contamination of heparin with oversulfated chondroitin sulfate","volume":"207","author":"Chess","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pr.115.011247_bib123","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1161\/ATVBAHA.111.235184","article-title":"Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin","volume":"31","author":"Chiodelli","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.115.011247_bib124","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bbapap.2014.08.002","article-title":"NMR characterization of the electrostatic interaction of the basic residues in HDGF and FGF2 during heparin binding","volume":"1844","author":"Chiu","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.115.011247_bib125","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/j.jchromb.2011.07.023","article-title":"The use of SAX-HPLC-CD as a heparin screening strategy","volume":"879","author":"Chmielewski","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/pr.115.011247_bib126","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0049-3848(80)90356-4","article-title":"Anti-Xa active heparin oligosaccharides","volume":"18","author":"Choay","year":"1980","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib127","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0006-291X(83)90550-8","article-title":"Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity","volume":"116","author":"Choay","year":"1983","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.115.011247_bib128","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1445-5994.1986.tb00023.x","article-title":"Platelet proaggregating effect of heparin: possible mechanism for non-immune heparin-associated thrombocytopenia","volume":"16","author":"Chong","year":"1986","journal-title":"Aust N Z J Med"},{"key":"10.1124\/pr.115.011247_bib129","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1021\/bi9926025","article-title":"An NMR and molecular modeling study of the site-specific binding of histamine by heparin, chemically modified heparin, and heparin-derived oligosaccharides","volume":"39","author":"Chuang","year":"2000","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0021-9673(01)01241-9","article-title":"Chromatographic methods for product-profile analysis and isolation of oligosaccharides produced by heparinase-catalyzed depolymerization of heparin","volume":"932","author":"Chuang","year":"2001","journal-title":"J Chromatogr A"},{"key":"10.1124\/pr.115.011247_bib131","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0008-6215(02)00050-2","article-title":"Hexasaccharides from the histamine-modified depolymerization of porcine intestinal mucosal heparin","volume":"337","author":"Chuang","year":"2002","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib1500","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-0037-1612949","article-title":"The APTT response of pregnant plasma to unfractionated heparin","volume":"87","author":"Chunilal","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib132","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0006-291X(62)90141-9","article-title":"The uronic acid of heparin","volume":"7","author":"Cifonelli","year":"1962","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.115.011247_bib133","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM198703053161004","article-title":"Immune endothelial-cell injury in heparin-associated thrombocytopenia","volume":"316","author":"Cines","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.115.011247_bib134","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.4049\/jimmunol.1201751","article-title":"Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions","volume":"190","author":"Clark","year":"2013","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011247_bib135","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/glycob\/cwq046","article-title":"NMR characterization and molecular modeling of fucoidan showing the importance of oligosaccharide branching in its anticomplementary activity","volume":"20","author":"Cl\u00e9ment","year":"2010","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib136","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/265625a0","article-title":"Suppression by heparin of smooth muscle cell proliferation in injured arteries","volume":"265","author":"Clowes","year":"1977","journal-title":"Nature"},{"key":"10.1124\/pr.115.011247_bib137","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.thromres.2013.09.040","article-title":"Managing pulmonary embolism from presentation to extended treatment","volume":"133","author":"Cohen","year":"2014","journal-title":"Thromb Res"},{"issue":"Suppl 2","key":"10.1124\/pr.115.011247_bib138","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0049-3848(10)70008-6","article-title":"VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients","volume":"125","author":"Cohen","year":"2010","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib139","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1021\/bi011711s","article-title":"Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro","volume":"41","author":"Cohlberg","year":"2002","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/320445a0","article-title":"Neuronal cell-cell adhesion depends on interactions of N-CAM with heparin-like molecules","volume":"320","author":"Cole","year":"1986","journal-title":"Nature"},{"key":"10.1124\/pr.115.011247_bib141","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0167-4838(99)00051-5","article-title":"Amino acid residues of heparin cofactor II required for stimulation of thrombin inhibition by sulphated polyanions","volume":"1431","author":"Colwell","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.115.011247_bib142","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI110584","article-title":"Activation of protein C in vivo","volume":"70","author":"Comp","year":"1982","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.115.011247_bib143","series-title":"Heparin-Binding Proteins","author":"Conrad","year":"1997"},{"key":"10.1124\/pr.115.011247_bib144","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/cc6810","article-title":"Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors","volume":"12","author":"Cook","year":"2008","journal-title":"Crit Care"},{"key":"10.1124\/pr.115.011247_bib145","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa1014475","article-title":"Dalteparin versus unfractionated heparin in critically ill patients","volume":"364","author":"Cook","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.115.011247_bib146","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00018-004-4293-7","article-title":"Heparan sulfate-protein interactions: therapeutic potential through structure-function insights","volume":"62","author":"Coombe","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/pr.115.011247_bib147","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1021\/bi7024595","article-title":"Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 2. Biochemical analyses","volume":"47","author":"Coombe","year":"2008","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib148","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00004630-199803000-00002","article-title":"Acceleration of partial-thickness burn wound healing with topical application of heparin-binding EGF-like growth factor (HB-EGF)","volume":"19","author":"Cribbs","year":"1998","journal-title":"J Burn Care Rehabil"},{"key":"10.1124\/pr.115.011247_bib149","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1525-139X.2010.00770.x","article-title":"Unfractionated heparin for hemodialysis: still the best option","volume":"23","author":"Cronin","year":"2010","journal-title":"Semin Dial"},{"key":"10.1124\/pr.115.011247_bib150","doi-asserted-by":"crossref","first-page":"15193","DOI":"10.1074\/jbc.M800066200","article-title":"The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site","volume":"283","author":"Crublet","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib151","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1471-4159.2012.07929.x","article-title":"Size and sulfation are critical for the effect of heparin on APP processing and A\u03b2 production","volume":"123","author":"Cui","year":"2012","journal-title":"J Neurochem"},{"key":"10.1124\/pr.115.011247_bib152","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1378\/chest.122.4.1440","article-title":"Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis","volume":"122","author":"Dalen","year":"2002","journal-title":"Chest"},{"key":"10.1124\/pr.115.011247_bib153","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1378\/chest.122.5.1801","article-title":"Pulmonary embolism: what have we learned since Virchow?: treatment and prevention","volume":"122","author":"Dalen","year":"2002","journal-title":"Chest"},{"key":"10.1124\/pr.115.011247_bib154","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1074\/jbc.M110.160184","article-title":"Structural basis of oligosaccharide receptor recognition by human papillomavirus","volume":"286","author":"Dasgupta","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib155","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1124\/jpet.112.201491","article-title":"An engineered human follistatin variant: insights into the pharmacokinetic and pharmocodynamic relationships of a novel molecule with broad therapeutic potential","volume":"344","author":"Datta-Mannan","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.115.011247_bib156","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrneph.2011.88","article-title":"What are the anticoagulation options for intermittent hemodialysis?","volume":"7","author":"Davenport","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1124\/pr.115.011247_bib157","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7196\/SAMJ.3647","article-title":"Endogenous heparin levels in the controlled asthmatic patient","volume":"100","author":"Davids","year":"2010","journal-title":"S Afr Med J"},{"key":"10.1124\/pr.115.011247_bib158","first-page":"583","article-title":"An unexpected role for anticoagulant heparan sulfate proteoglycans in reproduction","volume":"136","author":"de Agostini","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"10.1124\/pr.115.011247_bib159","doi-asserted-by":"crossref","first-page":"28115","DOI":"10.1074\/jbc.M805338200","article-title":"Human follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity","volume":"283","author":"de Agostini","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-9378(89)90096-3","article-title":"Enhanced thrombin generation in normal and hypertensive pregnancy","volume":"160","author":"de Boer","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/pr.115.011247_bib161","doi-asserted-by":"crossref","first-page":"13767","DOI":"10.1128\/JVI.01364-12","article-title":"Heparan sulfate facilitates Rift Valley fever virus entry into the cell","volume":"86","author":"de Boer","year":"2012","journal-title":"J Virol"},{"key":"10.1124\/pr.115.011247_bib162","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/1570161113666141229115302","article-title":"Recent advances in optimal adjunctive antithrombotic therapy in STEMI patients undergoing primary angioplasty: an overview","volume":"13","author":"De Luca","year":"2015","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1124\/pr.115.011247_bib163","doi-asserted-by":"crossref","first-page":"22969","DOI":"10.1074\/jbc.M114.572529","article-title":"Unique properties of human \u03b2-defensin 6 (hBD6) and glycosaminoglycan complex: sandwich-like dimerization and competition with the chemokine receptor 2 (CCR2) binding site","volume":"289","author":"De Paula","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib164","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/1439-7633(20010903)2:9<673::AID-CBIC673>3.0.CO;2-7","article-title":"The activation of fibroblast growth factors by heparin: synthesis, structure, and biological activity of heparin-like oligosaccharides","volume":"2","author":"de Paz","year":"2001","journal-title":"ChemBioChem"},{"key":"10.1124\/pr.115.011247_bib165","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/cb700159m","article-title":"Profiling heparin-chemokine interactions using synthetic tools","volume":"2","author":"de Paz","year":"2007","journal-title":"ACS Chem Biol"},{"key":"10.1124\/pr.115.011247_bib166","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1074\/jbc.M807671200","article-title":"The binding properties of minimal oligosaccharides reveal a common heparan sulfate\/dermatan sulfate-binding site in hepatocyte growth factor\/scatter factor that can accommodate a wide variety of sulfation patterns","volume":"284","author":"Deakin","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib167","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/glycob\/cwt016","article-title":"Chemoenzymatic synthesis of glycosaminoglycans: re-creating, re-modeling and re-designing nature\u2019s longest or most complex carbohydrate chains","volume":"23","author":"DeAngelis","year":"2013","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib168","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jth.12071","article-title":"International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer","volume":"11","author":"Debourdeau","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib1004","unstructured":"Decramer M, Quintana P, Welte T (2013) ClinicalTrials.gov identifier: NCT 0045781."},{"key":"10.1124\/pr.115.011247_bib169","doi-asserted-by":"crossref","first-page":"12456","DOI":"10.1074\/jbc.M111345200","article-title":"Hepatocyte growth factor\/scatter factor binds to small heparin-derived oligosaccharides and stimulates the proliferation of human HaCaT keratinocytes","volume":"277","author":"Delehedde","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib170","doi-asserted-by":"crossref","first-page":"16037","DOI":"10.1016\/S0021-9258(18)82354-7","article-title":"Platelet\/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans","volume":"268","author":"DeLisser","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib171","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nsmb810","article-title":"The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity","volume":"11","author":"Dementiev","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/pr.115.011247_bib172","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.4049\/jimmunol.180.6.3680","article-title":"Monocyte cell surface glycosaminoglycans positively modulate IL-4-induced differentiation toward dendritic cells","volume":"180","author":"den Dekker","year":"2008","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011247_bib173","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1074\/jbc.M104852200","article-title":"Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies","volume":"277","author":"Dennissen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib174","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jps.2600840218","article-title":"Molecular weight of heparin using 13C nuclear magnetic resonance spectroscopy","volume":"84","author":"Desai","year":"1995","journal-title":"J Pharm Sci"},{"key":"10.1124\/pr.115.011247_bib175","doi-asserted-by":"crossref","first-page":"13033","DOI":"10.1021\/bi981426h","article-title":"Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites","volume":"37","author":"Desai","year":"1998","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib176","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008500.pub3","article-title":"Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy","volume":"8","author":"Di Nisio","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pr.115.011247_bib177","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1164\/ajrccm.153.6.8665036","article-title":"Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma","volume":"153","author":"Diamant","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/pr.115.011247_bib178","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1083\/jcb.130.6.1473","article-title":"Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b\/CD1)","volume":"130","author":"Diamond","year":"1995","journal-title":"J Cell Biol"},{"key":"10.1124\/pr.115.011247_bib179","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/31741","article-title":"Structure of a heparin-linked biologically active dimer of fibroblast growth factor","volume":"393","author":"DiGabriele","year":"1998","journal-title":"Nature"},{"key":"10.1124\/pr.115.011247_bib180","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1288\/00005537-196007000-00001","article-title":"The use of heparin as an anti-inflammatory agent","volume":"70","author":"Dolowitz","year":"1960","journal-title":"Laryngoscope"},{"key":"10.1124\/pr.115.011247_bib181","first-page":"309","article-title":"The use of heparin in the control of allergies","volume":"23","author":"Dolowitz","year":"1965","journal-title":"Ann Allergy"},{"key":"10.1124\/pr.115.011247_bib182","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1365-2125.2012.04302.x","article-title":"Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry","volume":"74","author":"Donath","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/pr.115.011247_bib183","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1021\/ac802770r","article-title":"Analysis of oligosaccharides derived from heparin by ion-pair reversed-phase chromatography\/mass spectrometry","volume":"81","author":"Doneanu","year":"2009","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib184","first-page":"229","article-title":"Rapports du foie avec la coagulation du sang. Conditions de l'incoagulabilite du sang circulant","volume":"14","author":"Doyon","year":"1912","journal-title":"J Physiolet Pathgen"},{"key":"10.1124\/pr.115.011247_bib185","first-page":"266","article-title":"Heparin-induced skin necrosis and low molecular weight heparins","volume":"81","author":"Drew","year":"1999","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1124\/pr.115.011247_bib186","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-3-642-23056-1_14","article-title":"Glycosaminoglycans and neuroprotection","volume":"207","author":"Dudas","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pr.115.011247_bib187","doi-asserted-by":"crossref","first-page":"646","DOI":"10.7326\/0003-4819-100-5-646","article-title":"Transaminase elevations in patients receiving bovine or porcine heparin","volume":"100","author":"Dukes","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1124\/pr.115.011247_bib188","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1398-9995.2008.01707.x","article-title":"The effect of IVX-0142, a heparin-derived hypersulfated disaccharide, on the allergic airway responses in asthma","volume":"63","author":"Duong","year":"2008","journal-title":"Allergy"},{"key":"10.1124\/pr.115.011247_bib189","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/jps.2600810821","article-title":"Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives","volume":"81","author":"Edens","year":"1992","journal-title":"J Pharm Sci"},{"key":"10.1124\/pr.115.011247_bib190","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/jnci\/djh230","article-title":"Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis","volume":"96","author":"Edovitsky","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/pr.115.011247_bib191","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1182\/blood-2005-08-3301","article-title":"Role of endothelial heparanase in delayed-type hypersensitivity","volume":"107","author":"Edovitsky","year":"2006","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib192","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1016\/S0021-9258(19)44784-4","article-title":"The purification of a lipoprotein lipase from bovine skim milk","volume":"247","author":"Egelrud","year":"1972","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib193","doi-asserted-by":"crossref","first-page":"28943","DOI":"10.1074\/jbc.M109.038646","article-title":"Induced dimerization of the amyloid precursor protein leads to decreased amyloid-beta protein production","volume":"284","author":"Eggert","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib194","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1055\/s-0037-1614366","article-title":"Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden","volume":"82","author":"Eichinger","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib195","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/00016340903176818","article-title":"Low molecular weight heparin stimulates myometrial contractility and cervical remodeling in vitro","volume":"88","author":"Ekman-Ordeberg","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1124\/pr.115.011247_bib1007","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/00016340903294272","article-title":"Does low molecular weight heparin shorten term labor?","volume":"89","author":"Ekman-Orderberg","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1124\/pr.115.011247_bib196","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1055\/s-0034-1395153","article-title":"Tissue factor pathway inhibitor: then and now","volume":"40","author":"Ellery","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pr.115.011247_bib197","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/bjh.13147","article-title":"The use of fondaparinux in pregnancy","volume":"168","author":"Elsaigh","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1124\/pr.115.011247_bib198","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4137\/CMO.S18991","article-title":"Cancer-associated thrombosis: an overview","volume":"8","author":"Elyamany","year":"2014","journal-title":"Clin Med Insights Oncol"},{"key":"10.1124\/pr.115.011247_bib199","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<257::AID-CNCR1>3.0.CO;2-2","article-title":"Actions of heparin that may affect the malignant process","volume":"85","author":"Engelberg","year":"1999","journal-title":"Cancer"},{"key":"10.1124\/pr.115.011247_bib200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-9150(01)00650-5","article-title":"Endogenous heparin activity deficiency: the \u2018missing link\u2019 in atherogenesis?","volume":"159","author":"Engelberg","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.115.011247_bib201","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1073\/pnas.95.8.4182","article-title":"Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I","volume":"95","author":"Ernst","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib202","unstructured":"Proteoglycans and sulfated glycosaminoglycans, in Essentials of Glycobiology (Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, and Etzler ME, eds) 2nd ed, pp 229\u2013248, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY."},{"key":"10.1124\/pr.115.011247_bib203","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.biochem.71.110601.135458","article-title":"Order out of chaos: assembly of ligand binding sites in heparan sulfate","volume":"71","author":"Esko","year":"2002","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/pr.115.011247_bib204","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1538-7836.2008.02984.x","article-title":"Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials","volume":"6","author":"Ettema","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib205","series-title":"Assay of heparin, 01\/2015: 20705; 4187. The Directorate for the quality of medicines and healthcare of the council of Europe (EDQM)","year":"2015"},{"key":"10.1124\/pr.115.011247_bib206","doi-asserted-by":"crossref","first-page":"22307","DOI":"10.1016\/S0021-9258(18)54571-3","article-title":"Protease specificity and heparin binding and activation of recombinant protease nexin I","volume":"266","author":"Evans","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib207","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2036.1997.00252.x","article-title":"Treatment of corticosteroid-resistant ulcerative colitis with heparin--a report of 16 cases","volume":"11","author":"Evans","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/pr.115.011247_bib208","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1126\/science.271.5252.1116","article-title":"Heparin structure and interactions with basic fibroblast growth factor","volume":"271","author":"Faham","year":"1996","journal-title":"Science"},{"key":"10.1124\/pr.115.011247_bib209","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/annonc\/mdi165","article-title":"Deep vein thrombosis in cancer: the scale of the problem and approaches to management","volume":"16","author":"Falanga","year":"2005","journal-title":"Ann Oncol"},{"issue":"Suppl","key":"10.1124\/pr.115.011247_bib210","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1124\/pr.115.011247_bib211","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024951","article-title":"Characterization of the biosynthesis, processing and kinetic mechanism of action of the enzyme deficient in mucopolysaccharidosis IIIC","volume":"6","author":"Fan","year":"2011","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011247_bib212","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1472-6750-11-45","article-title":"Efficient production of human acidic fibroblast growth factor in pea (Pisum sativum L.) plants by agroinfection of germinated seeds","volume":"11","author":"Fan","year":"2011","journal-title":"BMC Biotechnol"},{"key":"10.1124\/pr.115.011247_bib213","doi-asserted-by":"crossref","first-page":"23608","DOI":"10.1074\/jbc.M110.206474","article-title":"Dual roles of the Cardin-Weintraub motif in multimeric Sonic hedgehog","volume":"286","author":"Farshi","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib214","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1083\/jcb.102.2.587","article-title":"A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells","volume":"102","author":"Fedarko","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1124\/pr.115.011247_bib1005","first-page":"3705","article-title":"Heparan sulfate 6-O-Sulfotransferase isoform-dependent regulatory effects of heparin on the activities of various proteases in mast cells and the biosynthesis of 6-O-sulfated heparin","volume":"288","author":"Ferdous","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jtv.2010.03.003","article-title":"Effects of topical application of 10,000\u00a0IU heparin on patients with perineal dermatitis and second-degree burns treated in a public pediatric hospital","volume":"19","author":"Ferreira Chacon","year":"2010","journal-title":"J Tissue Viability"},{"key":"10.1124\/pr.115.011247_bib216","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0008-6215(90)84164-P","article-title":"Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences","volume":"195","author":"Ferro","year":"1990","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib1006","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1074\/jbc.272.9.5518","article-title":"Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor","volume":"272","author":"Feyi","year":"1997","journal-title":"A Chain J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib217","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3390\/md9101731","article-title":"Therapies from fucoidan; multifunctional marine polymers","volume":"9","author":"Fitton","year":"2011","journal-title":"Mar Drugs"},{"key":"10.1124\/pr.115.011247_bib218","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9378(65)90518-1","article-title":"Placental transport of heparin","volume":"93","author":"Flessa","year":"1965","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/pr.115.011247_bib219","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0049-3848(84)90260-3","article-title":"Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound","volume":"34","author":"Forestier","year":"1984","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib220","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0038-1651102","article-title":"Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy","volume":"57","author":"Forestier","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib221","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/23488","article-title":"Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme","volume":"400","author":"Forsberg","year":"1999","journal-title":"Nature"},{"key":"10.1124\/pr.115.011247_bib222","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0263-7855(89)80002-5","article-title":"NOEMOL: integrated molecular graphics and the simulation of Nuclear Overhauser effects in NMR spectroscopy","volume":"7","author":"Forster","year":"1989","journal-title":"J Mol Graph"},{"key":"10.1124\/pr.115.011247_bib223","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1042\/BST0340431","article-title":"Computational approaches to the identification of heparin-binding sites on the surfaces of proteins","volume":"34","author":"Forster","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1124\/pr.115.011247_bib224","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/bip.360330407","article-title":"Molecular dynamics study of iduronate ring conformation","volume":"33","author":"Forster","year":"1993","journal-title":"Biopolymers"},{"key":"10.1124\/pr.115.011247_bib225","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1001\/jama.2014.15101","article-title":"Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients","volume":"312","author":"Fowler","year":"2014","journal-title":"JAMA"},{"key":"10.1124\/pr.115.011247_bib226","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/07853890.2015.1004361","article-title":"Low-molecular-weight heparins and cancer: focus on antitumoral effect","volume":"47","author":"Franchini","year":"2015","journal-title":"Ann Med"},{"key":"10.1124\/pr.115.011247_bib227","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11239-013-0889-9","article-title":"Prevention of VTE in patients having major orthopedic surgery","volume":"35","author":"Francis","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"10.1124\/pr.115.011247_bib228","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1398-9995.1991.tb00538.x","article-title":"In vitro studies of the interaction between heparin and eosinophil cationic protein","volume":"46","author":"Fredens","year":"1991","journal-title":"Allergy"},{"key":"10.1124\/pr.115.011247_bib229","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1042\/bj2820899","article-title":"Human alpha-L-iduronidase. Catalytic properties and an integrated role in the lysosomal degradation of heparan sulphate","volume":"282","author":"Freeman","year":"1992","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib230","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0741-5214(92)90164-4","article-title":"Heparin, urokinase, and ancrod alter neutrophil function","volume":"16","author":"Freischlag","year":"1992","journal-title":"J Vasc Surg"},{"key":"10.1124\/pr.115.011247_bib231","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bcp.2006.05.006","article-title":"The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity","volume":"72","author":"Fritzsche","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.115.011247_bib232","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/emboj\/18.3.543","article-title":"The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex","volume":"18","author":"Fry","year":"1999","journal-title":"EMBO J"},{"key":"10.1124\/pr.115.011247_bib233","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1099\/vir.0.80730-0","article-title":"Structure of Foot-and-mouth disease virus serotype A10 61 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation","volume":"86","author":"Fry","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1124\/pr.115.011247_bib234","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0022-3565(24)36816-8","article-title":"Selective O-desulfation produces nonanticoagulant heparin that retains pharmacological activity in the lung","volume":"282","author":"Fryer","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.115.011247_bib235","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/jps.23939","article-title":"Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration","volume":"103","author":"Fu","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1124\/pr.115.011247_bib236","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1039\/c2an35552c","article-title":"Ultrasensitive colorimetric detection of heparin based on self-assembly of gold nanoparticles on graphene oxide","volume":"137","author":"Fu","year":"2012","journal-title":"Analyst (Lond)"},{"key":"10.1124\/pr.115.011247_bib237","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bios.2012.02.008","article-title":"Label-free colorimetric sensor for ultrasensitive detection of heparin based on color quenching of gold nanorods by graphene oxide","volume":"34","author":"Fu","year":"2012","journal-title":"Biosens Bioelectron"},{"key":"10.1124\/pr.115.011247_bib238","first-page":"220","article-title":"Paradoxical response to heparin in 10 patients with ulcerative colitis","volume":"90","author":"Gaffney","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1124\/pr.115.011247_bib239","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0140-6736(91)92201-C","article-title":"Response to heparin in patients with ulcerative colitis","volume":"337","author":"Gaffney","year":"1991","journal-title":"Lancet"},{"key":"10.1124\/pr.115.011247_bib240","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/bj1900243","article-title":"Synthesis of glycosaminoglycans by human skin fibroblasts cultured on collagen gels","volume":"190","author":"Gallagher","year":"1980","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib241","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/bj2360313","article-title":"Structure and function of heparan sulphate proteoglycans","volume":"236","author":"Gallagher","year":"1986","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib242","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1021\/bi702455e","article-title":"Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 1. Molecular modeling studies","volume":"47","author":"Gandhi","year":"2008","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib243","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.carres.2009.12.020","article-title":"Can current force fields reproduce ring puckering in 2-O-sulfo-alpha-L-iduronic acid? A molecular dynamics simulation study","volume":"345","author":"Gandhi","year":"2010","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib244","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.bbapap.2012.07.002","article-title":"Prediction of heparin binding sites in bone morphogenetic proteins (BMPs)","volume":"1824","author":"Gandhi","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.115.011247_bib1009","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1073\/pnas.0400744101","article-title":"Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation","volume":"101","author":"Ganesh","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib245","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1021\/cb300386v","article-title":"Insights into the glycosaminoglycan-mediated cytotoxic mechanism of eosinophil cationic protein revealed by NMR","volume":"8","author":"Garc\u00eda-Mayoral","year":"2013","journal-title":"ACS Chem Biol"},{"issue":"Suppl","key":"10.1124\/pr.115.011247_bib246","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"10.1124\/pr.115.011247_bib247","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4049\/jimmunol.1000184","article-title":"Cutting edge: C1q binds deoxyribose and heparan sulfate through neighboring sites of its recognition domain","volume":"185","author":"Garlatti","year":"2010","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011247_bib248","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0003-9861(73)90470-0","article-title":"Heparin-polypeptide interactions in aqueous solution","volume":"159","author":"Gelman","year":"1973","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/pr.115.011247_bib249","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1021\/ac902836e","article-title":"Reversible detection of heparin and other polyanions by pulsed chronopotentiometric polymer membrane electrode","volume":"82","author":"Gemene","year":"2010","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib250","doi-asserted-by":"crossref","first-page":"11075","DOI":"10.1016\/S0021-9258(18)37923-7","article-title":"Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin","volume":"263","author":"Ghosh","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib251","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1021\/ac3016054","article-title":"Mass spectrometric method for determining the uronic acid epimerization in heparan sulfate disaccharides generated using nitrous acid","volume":"84","author":"Gill","year":"2012","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib252","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1083\/jcb.136.4.945","article-title":"Monocyte adhesion to activated aortic endothelium: role of L-selectin and heparan sulfate proteoglycans","volume":"136","author":"Giuffr\u00e8","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1124\/pr.115.011247_bib253","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/glycob\/cwu119","article-title":"Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: Effect on P-selectin, heparanase, metastasis and cellular recruitment","volume":"25","author":"Gomes","year":"2015","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib254","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.thromres.2014.06.020","article-title":"Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis","volume":"134","author":"G\u00f3mez-Outes","year":"2014","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib255","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3675","article-title":"Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons","volume":"344","author":"G\u00f3mez-Outes","year":"2012","journal-title":"BMJ"},{"key":"10.1124\/pr.115.011247_bib256","doi-asserted-by":"crossref","first-page":"35152","DOI":"10.1074\/jbc.M300925200","article-title":"Processing of macromolecular heparin by heparanase","volume":"278","author":"Gong","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib257","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0026-2862(82)80010-1","article-title":"Increased adhesiveness of granulocytes in rabbit ear-chamber blood vessels perfused with neuraminidase","volume":"23","author":"G\u00f6r\u00f6g","year":"1982","journal-title":"Microvasc Res"},{"key":"10.1124\/pr.115.011247_bib258","first-page":"2251","article-title":"New strategies of heparin treatment used to prolong allograft survival","volume":"23","author":"Gorski","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1124\/pr.115.011247_bib259","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1515\/BC.2006.139","article-title":"Heparin modulation of human plasma kallikrein on different substrates and inhibitors","volume":"387","author":"Gozzo","year":"2006","journal-title":"Biol Chem"},{"key":"10.1124\/pr.115.011247_bib260","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1590\/S0100-879X2003000800011","article-title":"Glycosaminoglycans affect the interaction of human plasma kallikrein with plasminogen, factor XII and inhibitors","volume":"36","author":"Gozzo","year":"2003","journal-title":"Braz J Med Biol Res"},{"key":"10.1124\/pr.115.011247_bib261","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jmb.2005.12.053","article-title":"Solution conformation and heparin-induced dimerization of the full-length extracellular domain of the human amyloid precursor protein","volume":"357","author":"Gralle","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1124\/pr.115.011247_bib262","first-page":"47","article-title":"Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study","volume":"27","author":"Grassegger","year":"2001","journal-title":"Dermatol Surg"},{"key":"10.1124\/pr.115.011247_bib263","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-642-23056-1_4","article-title":"Standardisation of unfractionated and low-molecular-weight heparin","volume":"207","author":"Gray","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pr.115.011247_bib264","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-642-23056-1_3","article-title":"The anticoagulant and antithrombotic mechanisms of heparin","volume":"207","author":"Gray","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pr.115.011247_bib265","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1160\/TH08-01-0032","article-title":"Heparin and low-molecular-weight heparin","volume":"99","author":"Gray","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib266","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1165\/ajrcmb\/8.5.518","article-title":"Effect of salbutamol, fenoterol, and sodium cromoglycate on the release of heparin from sensitized human lung fragments challenged with Dermatophagoides pteronyssinus allergen","volume":"8","author":"Green","year":"1993","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/pr.115.011247_bib267","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2141.2004.05304.x","article-title":"Low molecular weight heparin in pregnancy: current issues","volume":"128","author":"Greer","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1124\/pr.115.011247_bib268","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib269","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.thromres.2007.11.007","article-title":"Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings","volume":"122","author":"Greinacher","year":"2008","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib270","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.ATV.0000238350.89477.88","article-title":"Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies","volume":"26","author":"Greinacher","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.115.011247_bib271","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1182\/blood-2008-08-173062","article-title":"The temporal profile of the anti-PF4\/heparin immune response","volume":"113","author":"Greinacher","year":"2009","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib272","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1160\/TH14-11-0982","article-title":"Reversal of anticoagulants: an overview of current developments","volume":"113","author":"Greinacher","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib1008","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1165\/rcmb.2013-0338RC","article-title":"2-O, 3-O-desulfated heparin inhibits neutrophil elastase-induced HMGB-1 secretion and airway inflammation","volume":"50","author":"Griffin","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/pr.115.011247_bib273","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jama.1965.03090020005001","article-title":"Heparin osteoporosis","volume":"193","author":"Griffith","year":"1965","journal-title":"JAMA"},{"key":"10.1124\/pr.115.011247_bib274","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nature01245","article-title":"Structural basis of BMP signalling inhibition by the cystine knot protein Noggin","volume":"420","author":"Groppe","year":"2002","journal-title":"Nature"},{"key":"10.1124\/pr.115.011247_bib275","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nbt1407","article-title":"Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events","volume":"26","author":"Guerrini","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1124\/pr.115.011247_bib276","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-642-23056-1_7","article-title":"Low-molecular-weight heparins: differential characterization\/physical characterization","volume":"207","author":"Guerrini","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pr.115.011247_bib277","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1021\/jm100771s","article-title":"Effects on molecular conformation and anticoagulant activities of 1,6-anhydrosugars at the reducing terminal of antithrombin-binding octasaccharides isolated from low-molecular-weight heparin enoxaparin","volume":"53","author":"Guerrini","year":"2010","journal-title":"J Med Chem"},{"key":"10.1124\/pr.115.011247_bib278","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/BJ20121309","article-title":"An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence","volume":"449","author":"Guerrini","year":"2013","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib279","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1160\/TH09-02-0079","article-title":"The tainted heparin story: an update","volume":"102","author":"Guerrini","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib280","doi-asserted-by":"crossref","first-page":"16956","DOI":"10.1073\/pnas.0906861106","article-title":"Orthogonal analytical approaches to detect potential contaminants in heparin","volume":"106","author":"Guerrini","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib281","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/bjh.13159","article-title":"The prevention of pregnancy-related venous thromboembolism","volume":"168","author":"Guimicheva","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1124\/pr.115.011247_bib282","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.RES.46.5.625","article-title":"Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin","volume":"46","author":"Guyton","year":"1980","journal-title":"Circ Res"},{"key":"10.1124\/pr.115.011247_bib283","doi-asserted-by":"crossref","first-page":"14631","DOI":"10.1074\/jbc.M313760200","article-title":"Irreversible glucuronyl C5-epimerization in the biosynthesis of heparan sulfate","volume":"279","author":"Hagner-McWhirter","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib284","series-title":"Mallard: How the Blue Streak Broke the World Steam Speed Record","author":"Hale","year":"2005"},{"key":"10.1124\/pr.115.011247_bib285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jmb.2004.10.029","article-title":"Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase","volume":"345","author":"Hallgren","year":"2005","journal-title":"J Mol Biol"},{"key":"10.1124\/pr.115.011247_bib286","doi-asserted-by":"crossref","first-page":"34019","DOI":"10.1074\/jbc.M109.025338","article-title":"Structural snapshots of heparin depolymerization by heparin lyase I","volume":"284","author":"Han","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib970","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.biochem.72.121801.161747","article-title":"Regulation or protein function by glycosaminoglycans as exemplified by chemokines","volume":"74","author":"Handel","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/pr.115.011247_bib287","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00423-004-0522-7","article-title":"Low molecular weight heparin-induced skin necrosis-a systematic review","volume":"390","author":"Handschin","year":"2005","journal-title":"Langenbecks Arch Surg"},{"key":"10.1124\/pr.115.011247_bib288","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0167-4838(95)00113-9","article-title":"Identification of a homologous heparin binding peptide sequence present in fibronectin and the 70 kDa family of heat-shock proteins","volume":"1252","author":"Hansen","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.115.011247_bib289","doi-asserted-by":"crossref","first-page":"7823","DOI":"10.1021\/jo300722y","article-title":"Synthesis and scalable conversion of L-iduronamides to heparin-related di- and tetrasaccharides","volume":"77","author":"Hansen","year":"2012","journal-title":"J Org Chem"},{"key":"10.1124\/pr.115.011247_bib290","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/ncomms3016","article-title":"Tetrasaccharide iteration synthesis of a heparin-like dodecasaccharide and radiolabelling for in vivo tissue distribution studies","volume":"4","author":"Hansen","year":"2013","journal-title":"Nat Commun"},{"key":"10.1124\/pr.115.011247_bib291","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/ol303112y","article-title":"First gram-scale synthesis of a heparin-related dodecasaccharide","volume":"15","author":"Hansen","year":"2013","journal-title":"Org Lett"},{"key":"10.1124\/pr.115.011247_bib292","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MBC.0000000000000205","article-title":"Rivaroxaban for arterial thrombosis related to heparin-induced thrombocytopenia","volume":"26","author":"Hantson","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1124\/pr.115.011247_bib294","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0021-9673(01)87952-8","article-title":"Characterization of heparins by high performance size exclusion liquid chromatography","volume":"261","author":"Harenberg","year":"1983","journal-title":"J Chromatogr A"},{"key":"10.1124\/pr.115.011247_bib295","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jmb.2004.04.031","article-title":"Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGF receptor-heparin complex","volume":"339","author":"Harmer","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1124\/pr.115.011247_bib296","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/bi035320k","article-title":"The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity","volume":"43","author":"Harmer","year":"2004","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib297","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1398-9995.2006.01063.x","article-title":"Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux","volume":"61","author":"Harr","year":"2006","journal-title":"Allergy"},{"key":"10.1124\/pr.115.011247_bib298","doi-asserted-by":"crossref","first-page":"17341","DOI":"10.1074\/jbc.M710360200","article-title":"The human hyaluronan receptor for endocytosis (HARE\/Stabilin-2) is a systemic clearance receptor for heparin","volume":"283","author":"Harris","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib1010","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4049\/jimmunol.162.2.1064","article-title":"IL-12 is a heparin-binding cytokine","volume":"162","author":"Hasan","year":"1999","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011247_bib299","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.biologicals.2010.04.002","article-title":"Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography","volume":"38","author":"Hashii","year":"2010","journal-title":"Biologicals"},{"key":"10.1124\/pr.115.011247_bib300","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1172\/JCI0213432","article-title":"Heparin cofactor II inhibits arterial thrombosis after endothelial injury","volume":"109","author":"He","year":"2002","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"10.1124\/pr.115.011247_bib301","article-title":"Dalteparin shortens human labour","volume":"5","author":"Hellgren","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib302","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1515\/hsz-2013-0211","article-title":"Granule proteases of hematopoietic cells, a family of versatile inflammatory mediators - an update on their cleavage specificity, in vivo substrates, and evolution","volume":"395","author":"Hellman","year":"2014","journal-title":"Biol Chem"},{"key":"10.1124\/pr.115.011247_bib303","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1055\/s-0037-1615937","article-title":"Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread","volume":"82","author":"Hettiarachchi","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib304","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.0.CO;2-R","article-title":"Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins","volume":"20","author":"Hileman","year":"1998","journal-title":"BioEssays"},{"key":"10.1124\/pr.115.011247_bib305","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00000441-195403000-00007","article-title":"Alopecia and other toxic effects of heparin and synthetic heparinoids","volume":"227","author":"Hirschboeck","year":"1954","journal-title":"Am J Med Sci"},{"key":"10.1124\/pr.115.011247_bib306","first-page":"2","article-title":"Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures","volume":"65","author":"Hirsh","year":"1989","journal-title":"Br J Clin Pract Suppl"},{"issue":"Suppl","key":"10.1124\/pr.115.011247_bib307","doi-asserted-by":"crossref","first-page":"188S","DOI":"10.1378\/chest.126.3_suppl.188S","article-title":"Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Hirsh","year":"2004","journal-title":"Chest"},{"issue":"Suppl","key":"10.1124\/pr.115.011247_bib308","doi-asserted-by":"crossref","first-page":"258S","DOI":"10.1378\/chest.108.4_Supplement.258S","article-title":"Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety","volume":"108","author":"Hirsh","year":"1995","journal-title":"Chest"},{"issue":"Suppl","key":"10.1124\/pr.115.011247_bib309","doi-asserted-by":"crossref","first-page":"489S","DOI":"10.1378\/chest.114.5_Supplement.489S","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety","volume":"114","author":"Hirsh","year":"1998","journal-title":"Chest"},{"issue":"Suppl","key":"10.1124\/pr.115.011247_bib310","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1378\/chest.119.1_suppl.64S","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"10.1124\/pr.115.011247_bib311","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1160\/TH03-11-0719","article-title":"Prospective evaluation of coagulation activation in pregnant women receiving low-molecular weight heparin","volume":"91","author":"Hoke","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib312","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/BST20140064","article-title":"Using embryonic stem cells to understand how glycosaminoglycans regulate differentiation","volume":"42","author":"Holley","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"10.1124\/pr.115.011247_bib313","first-page":"428","article-title":"Delivery of low molecular weight heparin for prophylaxis against deep vein thrombosis using a novel, needle-less injection device (J-Tip)","volume":"82","author":"Hollingsworth","year":"2000","journal-title":"Ann R Coll Surg Engl"},{"issue":"Suppl 2","key":"10.1124\/pr.115.011247_bib314","first-page":"30","article-title":"Subcutaneous heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin","volume":"16","author":"Holm","year":"1986","journal-title":"Haemostasis"},{"key":"10.1124\/pr.115.011247_bib315","doi-asserted-by":"crossref","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","article-title":"Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds","volume":"110","author":"Holmes","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib316","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1038\/srep03420","article-title":"Guiding the osteogenic fate of mouse and human mesenchymal stem cells through feedback system control","volume":"3","author":"Honda","year":"2013","journal-title":"Sci Rep"},{"key":"10.1124\/pr.115.011247_bib317","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0014-5793(76)80592-3","article-title":"Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin","volume":"66","author":"H\u00f6\u00f6k","year":"1976","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.115.011247_bib318","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0196-0644(99)70104-6","article-title":"New-generation anticoagulants: the low molecular weight heparins","volume":"34","author":"Hovanessian","year":"1999","journal-title":"Ann Emerg Med"},{"key":"10.1124\/pr.115.011247_bib319","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1586\/17512433.2014.923306","article-title":"Recent advances in antithrombotic treatment for acute coronary syndromes","volume":"7","author":"Howard","year":"2014","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1124\/pr.115.011247_bib320","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1152\/ajplegacy.1918.47.3.328","article-title":"the new factors in blood coagulation - heparin and pro-antithrombin","volume":"47","author":"Howell","year":"1918","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.011247_bib321","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1471-0528.1983.tb06458.x","article-title":"The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial","volume":"90","author":"Howell","year":"1983","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1124\/pr.115.011247_bib322","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/jp1098552","article-title":"Effect of solvent and counterions upon structure and NMR spin-spin coupling constants in heparin disaccharide","volume":"115","author":"Hricov\u00edni","year":"2011","journal-title":"J Phys Chem B"},{"key":"10.1124\/pr.115.011247_bib323","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.chroma.2010.03.023","article-title":"Purification of porcine reproductive and respiratory syndrome virus from cell culture using ultrafiltration and heparin affinity chromatography","volume":"1217","author":"Hu","year":"2010","journal-title":"J Chromatogr A"},{"key":"10.1124\/pr.115.011247_bib324","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/ac802626e","article-title":"Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application","volume":"81","author":"Hu","year":"2009","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib325","first-page":"2268","article-title":"Collective sampling of intact anionic polysaccharide components and application in quantitative determination by LC-MS","volume":"346","author":"Hu","year":"2011","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib326","doi-asserted-by":"crossref","first-page":"20722","DOI":"10.1021\/ja3090065","article-title":"Divergent synthesis of 48 heparan sulfate-based disaccharides and probing the specific sugar-fibroblast growth factor-1 interaction","volume":"134","author":"Hu","year":"2012","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.115.011247_bib327","article-title":"Low-molecular-weight heparin and unfractionated heparin decrease Th-1, 2, and 17 expressions","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011247_bib328","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1074\/jbc.M110.188375","article-title":"Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor","volume":"286","author":"Huang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib329","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood.V96.1.188","article-title":"Morphological analysis of microparticle generation in heparin-induced thrombocytopenia","volume":"96","author":"Hughes","year":"2000","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib330","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.thromres.2014.09.036","article-title":"Silent pulmonary embolism in patients with distal deep venous thrombosis: systematic review","volume":"134","author":"Hughes","year":"2014","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib331","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1378\/chest.95.3.498","article-title":"Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis","volume":"95","author":"Huisman","year":"1989","journal-title":"Chest"},{"key":"10.1124\/pr.115.011247_bib332","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM199204093261502","article-title":"Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis","volume":"326","author":"Hull","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.115.011247_bib333","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/23481","article-title":"Heparin is essential for the storage of specific granule proteases in mast cells","volume":"400","author":"Humphries","year":"1999","journal-title":"Nature"},{"key":"10.1124\/pr.115.011247_bib334","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1046\/j.1538-7836.2003.00305.x","article-title":"Mechanisms of glycosaminoglycan activation of the serpins in hemostasis","volume":"1","author":"Huntington","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib335","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2006.06.005","article-title":"Shape-shifting serpins--advantages of a mobile mechanism","volume":"31","author":"Huntington","year":"2006","journal-title":"Trends Biochem Sci"},{"issue":"Suppl 1","key":"10.1124\/pr.115.011247_bib336","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1538-7836.2011.04360.x","article-title":"Serpin structure, function and dysfunction","volume":"9","author":"Huntington","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"10.1124\/pr.115.011247_bib337","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jth.12252","article-title":"Thrombin inhibition by the serpins","volume":"11","author":"Huntington","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib338","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1160\/TH13-10-0811","article-title":"Natural inhibitors of thrombin","volume":"111","author":"Huntington","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib339","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.biocel.2006.06.004","article-title":"Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis","volume":"38","author":"Ilan","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1124\/pr.115.011247_bib340","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.carres.2006.12.019","article-title":"Structural view of glycosaminoglycan-protein interactions","volume":"342","author":"Imberty","year":"2007","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib341","first-page":"L387","article-title":"Heparin inhibits histamine release from canine mast cells","volume":"264","author":"Inase","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.011247_bib342","doi-asserted-by":"crossref","first-page":"39969","DOI":"10.1074\/jbc.M211284200","article-title":"Crystal structures of the heparan sulfate-binding domain of follistatin. Insights into ligand binding","volume":"278","author":"Innis","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib343","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1124\/pr.115.011247_bib344","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bone.2007.04.190","article-title":"Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity","volume":"41","author":"Irie","year":"2007","journal-title":"Bone"},{"key":"10.1124\/pr.115.011247_bib345","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/jth.12698","article-title":"Thrombosis: a major contributor to the global disease burden","volume":"12","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib346","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1042\/bj1240677","article-title":"Coupling of glycosaminoglycans to agarose beads (sepharose 4B)","volume":"124","author":"Iverius","year":"1971","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib347","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1016\/S0021-9258(19)44735-2","article-title":"Effects of heparin on lipoprotein lipase from bovine milk","volume":"247","author":"Iverius","year":"1972","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib348","doi-asserted-by":"crossref","first-page":"34049","DOI":"10.1074\/jbc.M114.611707","article-title":"Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease","volume":"289","author":"Izaguirre","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib349","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/jama.1965.03090020072024","article-title":"Multiple fractures associated with long-term sodium heparin therapy","volume":"193","author":"Jaffe","year":"1965","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1124\/pr.115.011247_bib350","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.amjmed.2007.08.011","article-title":"Prevention and management of venous thromboembolism in pregnancy","volume":"120","author":"James","year":"2007","journal-title":"Am J Med"},{"key":"10.1124\/pr.115.011247_bib351","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/glycob\/4.3.289","article-title":"Action pattern of polysaccharide lyases on glycosaminoglycans","volume":"4","author":"Jandik","year":"1994","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib352","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/01.mbc.0000198992.18384.5a","article-title":"Allergy to heparins and anticoagulants with a similar pharmacological profile: an update","volume":"17","author":"Jappe","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1124\/pr.115.011247_bib353","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0031-6997(25)06829-2","article-title":"Heparins--anionic polyelectrolyte drugs","volume":"31","author":"Jaques","year":"1979","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.115.011247_bib354","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0006-291X(66)90181-1","article-title":"The structure of heparin. Proton magnetic resonance spectral observations","volume":"24","author":"Jaques","year":"1966","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.115.011247_bib355","first-page":"422","article-title":"Determination of absolute amounts of heparin and of dextran sulfate in plasma in microgram quantities","volume":"115","author":"Jaques","year":"1990","journal-title":"J Lab Clin Med"},{"key":"10.1124\/pr.115.011247_bib356","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jps.24134","article-title":"Stable isotopic analysis of porcine, bovine, and ovine heparins","volume":"104","author":"Jasper","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1124\/pr.115.011247_bib357","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/17474086.2014.954541","article-title":"Prevention and treatment of thrombosis associated with central venous catheters in cancer patients","volume":"7","author":"Jasti","year":"2014","journal-title":"Expert Rev Hematol"},{"key":"10.1124\/pr.115.011247_bib358","doi-asserted-by":"crossref","first-page":"26842","DOI":"10.1074\/jbc.M109.093542","article-title":"Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling","volume":"285","author":"Jastrebova","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib359","doi-asserted-by":"crossref","first-page":"26884","DOI":"10.1074\/jbc.M600806200","article-title":"Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors","volume":"281","author":"Jastrebova","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib360","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.1021\/bi4011682","article-title":"Relationship between structural flexibility and function in the C-terminal region of the heparin-binding domain of VEGF165","volume":"52","author":"Jeong","year":"2013","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib361","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.3748\/wjg.v10.i23.3490","article-title":"Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes","volume":"10","author":"Ji","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1124\/pr.115.011247_bib362","doi-asserted-by":"crossref","first-page":"14683","DOI":"10.1073\/pnas.94.26.14683","article-title":"The anticoagulant activation of antithrombin by heparin","volume":"94","author":"Jin","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib363","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1074\/jbc.M411309200","article-title":"Crystal structures of the FXIa catalytic domain in complex with ecotin mutants reveal substrate-like interactions","volume":"280","author":"Jin","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib364","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2162-3619-2-21","article-title":"Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance?","volume":"2","author":"Johansen","year":"2013","journal-title":"Exp Hematol Oncol"},{"key":"10.1124\/pr.115.011247_bib365","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1021\/bi034524y","article-title":"Crystal structure of antithrombin in a heparin-bound intermediate state","volume":"42","author":"Johnson","year":"2003","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib366","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1073\/pnas.0910144107","article-title":"Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex","volume":"107","author":"Johnson","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib367","doi-asserted-by":"crossref","first-page":"35478","DOI":"10.1074\/jbc.M607204200","article-title":"Crystal structure of monomeric native antithrombin reveals a novel reactive center loop conformation","volume":"281","author":"Johnson","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib368","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/sj.emboj.7601089","article-title":"Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation","volume":"25","author":"Johnson","year":"2006","journal-title":"EMBO J"},{"key":"10.1124\/pr.115.011247_bib369","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-0038-1648001","article-title":"Four heparin preparations: anti-Xa potentiating effect of heparin after subcutaneous injection","volume":"35","author":"Johnson","year":"1976","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib370","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0008-6215(00)84041-0","article-title":"The molecular-weight range of mucosal-heparin preparations","volume":"51","author":"Johnson","year":"1976","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib371","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.4049\/jimmunol.173.9.5776","article-title":"Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system","volume":"173","author":"Johnson","year":"2004","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011247_bib372","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-anchem-061010-113911","article-title":"Heparin characterization: challenges and solutions","volume":"4","author":"Jones","year":"2011","journal-title":"Annu Rev Anal Chem (Palo Alto, Calif)"},{"key":"10.1124\/pr.115.011247_bib373","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bjp.0704505","article-title":"The effects of heparin and related molecules on vascular permeability and neutrophil accumulation in rabbit skin","volume":"135","author":"Jones","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib374","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/bj0330047","article-title":"On the relationship between the sulphur content and the anticoagulant activity of heparin preparations","volume":"33","author":"Jorpes","year":"1939","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib375","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0021-9258(18)51026-7","article-title":"On heparin monosulfuric acid","volume":"176","author":"Jorpes","year":"1948","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib376","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.49.10.747","article-title":"Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase","volume":"49","author":"Jose","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1124\/pr.115.011247_bib377","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1038\/sj.onc.1208602","article-title":"A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer","volume":"24","author":"Joyce","year":"2005","journal-title":"Oncogene"},{"key":"10.1124\/pr.115.011247_bib378","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1681\/ASN.2005080868","article-title":"Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions","volume":"17","author":"J\u00f3zsi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.115.011247_bib379","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1073\/pnas.1018692108","article-title":"Structure of a Plasmodium falciparum PfEMP1 rosetting domain reveals a role for the N-terminal segment in heparin-mediated rosette inhibition","volume":"108","author":"Juillerat","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib380","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jb\/mvt035","article-title":"The heparin-binding growth factor midkine: the biological activities and candidate receptors","volume":"153","author":"Kadomatsu","year":"2013","journal-title":"J Biochem"},{"key":"10.1124\/pr.115.011247_bib381","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1021\/ac3015824","article-title":"Complete mass spectral characterization of a synthetic ultralow-molecular-weight heparin using collision-induced dissociation","volume":"84","author":"Kailemia","year":"2012","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib382","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/ac403969n","article-title":"Oligosaccharide analysis by mass spectrometry: a review of recent developments","volume":"86","author":"Kailemia","year":"2014","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib383","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jnr.490330406","article-title":"The neural cell adhesion molecule (NCAM) heparin binding domain binds to cell surface heparan sulfate proteoglycans","volume":"33","author":"Kallapur","year":"1992","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.115.011247_bib384","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.thromres.2006.03.010","article-title":"What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?","volume":"119","author":"Kamphuisen","year":"2007","journal-title":"Thromb Res"},{"issue":"Suppl 2","key":"10.1124\/pr.115.011247_bib385","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0049-3848(14)50009-6","article-title":"Bleeding complications during anticoagulant treatment in patients with cancer","volume":"133","author":"Kamphuisen","year":"2014","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib386","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.clinthera.2007.11.015","article-title":"Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients","volume":"29","author":"Kanaan","year":"2007","journal-title":"Clin Ther"},{"key":"10.1124\/pr.115.011247_bib387","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.bjp.0706333","article-title":"Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle","volume":"146","author":"Kanabar","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib388","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jconrel.2014.03.029","article-title":"Intracellular delivery of desulfated heparin with bile acid conjugation alleviates T cell-mediated inflammatory arthritis via inhibition of RhoA-dependent transcellular diapedesis","volume":"183","author":"Kang","year":"2014","journal-title":"J Control Release"},{"key":"10.1124\/pr.115.011247_bib389","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2014-09-599498","article-title":"Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study","volume":"125","author":"Kang","year":"2015","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib390","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1021\/ac103090m","article-title":"Highly sensitive potentiometric strip test for detecting high charge density impurities in heparin","volume":"83","author":"Kang","year":"2011","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib391","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1749-6632.1989.tb22509.x","article-title":"Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis","volume":"556","author":"Karnovsky","year":"1989","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/pr.115.011247_bib392","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.carres.2004.11.029","article-title":"Development of specific inhibitors for heparin-binding proteins based on the cobra cardiotoxin structure: an effective synthetic strategy for rationally modified heparin-like disaccharides and a trisaccharide","volume":"340","author":"Ke","year":"2005","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib393","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1182\/blood-2013-12-512681","article-title":"Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism","volume":"123","author":"Kearon","year":"2014","journal-title":"Blood"},{"issue":"Suppl","key":"10.1124\/pr.115.011247_bib394","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1124\/pr.115.011247_bib395","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jpba.2010.02.019","article-title":"Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches","volume":"52","author":"Keire","year":"2010","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pr.115.011247_bib396","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00216-010-4177-7","article-title":"(1)H NMR signal at 2.10\u00a0ppm in the spectrum of KMnO(4)-bleached heparin sodium: identification of the chemical origin using an NMR-only approach","volume":"399","author":"Kellenbach","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pr.115.011247_bib397","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.1981.03320140070035","article-title":"Cutaneous necrosis caused by systemically administered heparin","volume":"246","author":"Kelly","year":"1981","journal-title":"JAMA"},{"key":"10.1124\/pr.115.011247_bib398","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib399","doi-asserted-by":"crossref","first-page":"27737","DOI":"10.1074\/jbc.M113.492223","article-title":"The solution structure of heparan sulfate differs from that of heparin: implications for function","volume":"288","author":"Khan","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib400","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jmb.2009.10.064","article-title":"Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes","volume":"395","author":"Khan","year":"2010","journal-title":"J Mol Biol"},{"key":"10.1124\/pr.115.011247_bib401","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/BJ20120183","article-title":"Bivalent and co-operative binding of complement factor H to heparan sulfate and heparin","volume":"444","author":"Khan","year":"2012","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib402","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1160\/TH06-10-0606","article-title":"The management of thrombosis in pregnancy: role of low-molecular-weight heparin","volume":"97","author":"Kher","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib403","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.thromres.2009.12.023","article-title":"Venous thromboembolism and prognosis in cancer","volume":"125","author":"Khorana","year":"2010","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"10.1124\/pr.115.011247_bib404","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0049-3848(12)70009-9","article-title":"Risk assessment for cancer-associated thrombosis: what is the best approach?","volume":"129","author":"Khorana","year":"2012","journal-title":"Thromb Res"},{"issue":"Suppl 2","key":"10.1124\/pr.115.011247_bib405","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0049-3848(14)50006-0","article-title":"Risk stratification strategies for cancer-associated thrombosis: an update","volume":"133","author":"Khorana","year":"2014","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib406","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1161\/01.ATV.0000090671.56682.D7","article-title":"Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight","volume":"23","author":"Khorana","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.115.011247_bib407","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/j.1476-5381.1995.tb13367.x","article-title":"Inhibition of serum-induced proliferation of bovine tracheal smooth muscle cells in culture by heparin and related glycosaminoglycans","volume":"114","author":"Kilfeather","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib408","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0022-3565(24)35004-9","article-title":"Ex vivo reversal of heparin-mediated cardioprotection by heparinase after ischemia and reperfusion","volume":"290","author":"Kilgore","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.115.011247_bib409","article-title":"The choice of resin-bound ligand affects the structure and immunogenicity of column-purified human papillomavirus type 16 virus-like particles","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011247_bib410","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1089\/ten.tea.2009.0828","article-title":"Development of functional fibrous matrices for the controlled release of basic fibroblast growth factor to improve therapeutic angiogenesis","volume":"16","author":"Kim","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"10.1124\/pr.115.011247_bib411","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0002-9149(03)00972-X","article-title":"Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions","volume":"92","author":"Kinnaird","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1124\/pr.115.011247_bib412","doi-asserted-by":"crossref","first-page":"10125","DOI":"10.1074\/jbc.272.15.10125","article-title":"The first immunoglobulin-like neural cell adhesion molecule (NCAM) domain is involved in double-reciprocal interaction with the second immunoglobulin-like NCAM domain and in heparin binding","volume":"272","author":"Kiselyov","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib413","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","article-title":"Contaminated heparin associated with adverse clinical events and activation of the contact system","volume":"358","author":"Kishimoto","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.115.011247_bib414","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1111\/j.1471-4159.2010.06571.x","article-title":"Glycosaminoglycan-induced activation of the beta-secretase (BACE1) of Alzheimer\u2019s disease","volume":"112","author":"Klaver","year":"2010","journal-title":"J Neurochem"},{"key":"10.1124\/pr.115.011247_bib415","doi-asserted-by":"crossref","first-page":"27913","DOI":"10.1074\/jbc.M705127200","article-title":"Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate","volume":"282","author":"Knappe","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib416","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/abio.1996.9984","article-title":"Absolute molecular weight distribution of low-molecular-weight heparins by size-exclusion chromatography with multiangle laser light scattering detection","volume":"245","author":"Knobloch","year":"1997","journal-title":"Anal Biochem"},{"key":"10.1124\/pr.115.011247_bib417","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1038\/srep03178","article-title":"Analyses of interactions between heparin and the apical surface proteins of Plasmodium falciparum","volume":"3","author":"Kobayashi","year":"2013","journal-title":"Sci Rep"},{"key":"10.1124\/pr.115.011247_bib418","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1615\/JLongTermEffMedImplants.v10.i12.50","article-title":"Heparin-coated stents","volume":"10","author":"Kocsis","year":"2000","journal-title":"J Long Term Eff Med Implants"},{"key":"10.1124\/pr.115.011247_bib419","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1172\/JCI1509","article-title":"Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents","volume":"101","author":"Koenig","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.115.011247_bib420","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00018-007-7455-6","article-title":"Serglycin--structure and biology","volume":"65","author":"Kolset","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/pr.115.011247_bib421","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074043","article-title":"Ongoing contact activation in patients with hereditary angioedema","volume":"8","author":"Konings","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011247_bib422","first-page":"3145","article-title":"2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1124\/pr.115.011247_bib959","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1124\/pr.115.011247_bib423","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.4049\/jimmunol.163.4.2120","article-title":"Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1 beta","volume":"163","author":"Koopmann","year":"1999","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011247_bib424","doi-asserted-by":"crossref","first-page":"10103","DOI":"10.1074\/jbc.272.15.10103","article-title":"Identification of a glycosaminoglycan-binding site in chemokine macrophage inflammatory protein-1alpha","volume":"272","author":"Koopmann","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib425","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5301\/jva.5000183","article-title":"Efficacy of normal saline in the maintenance of the arterial lines in comparison to heparin flush: a comprehensive review of the literature","volume":"15","author":"Kordzadeh","year":"2014","journal-title":"J Vasc Access"},{"key":"10.1124\/pr.115.011247_bib426","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1021\/ac702235u","article-title":"Ultraperformance ion-pair liquid chromatography coupled to electrospray time-of-flight mass spectrometry for compositional profiling and quantification of heparin and heparan sulfate","volume":"80","author":"Korir","year":"2008","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib427","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1128\/JVI.02641-13","article-title":"Near-atomic resolution cryo-electron microscopic structure of dengue serotype 4 virus","volume":"88","author":"Kostyuchenko","year":"2014","journal-title":"J Virol"},{"key":"10.1124\/pr.115.011247_bib428","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s11883-009-0033-7","article-title":"Mast cells in atherogenesis: actions and reactions","volume":"11","author":"Kovanen","year":"2009","journal-title":"Curr Atheroscler Rep"},{"key":"10.1124\/pr.115.011247_bib429","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1538-7836.2011.04401.x","article-title":"Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin","volume":"9","author":"Kozlowski","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib430","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0022-4804(88)90014-5","article-title":"Anticoagulant effects of protamine sulfate in a canine model","volume":"45","author":"Kresowik","year":"1988","journal-title":"J Surg Res"},{"key":"10.1124\/pr.115.011247_bib431","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1042\/BJ20042129","article-title":"Fibroblast growth factors share binding sites in heparan sulphate","volume":"389","author":"Kreuger","year":"2005","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib432","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1369\/0022155412464972","article-title":"Heparan sulfate biosynthesis: regulation and variability","volume":"60","author":"Kreuger","year":"2012","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/pr.115.011247_bib433","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.1093\/emboj\/cdf638","article-title":"Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function","volume":"21","author":"Kreuger","year":"2002","journal-title":"EMBO J"},{"key":"10.1124\/pr.115.011247_bib434","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1083\/jcb.200604035","article-title":"Interactions between heparan sulfate and proteins: the concept of specificity","volume":"174","author":"Kreuger","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1124\/pr.115.011247_bib435","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/prot.10590","article-title":"A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations","volume":"54","author":"Krieger","year":"2004","journal-title":"Proteins"},{"key":"10.1124\/pr.115.011247_bib436","doi-asserted-by":"crossref","first-page":"28045","DOI":"10.1074\/jbc.M700319200","article-title":"Molecular mapping and functional characterization of the VEGF164 heparin-binding domain","volume":"282","author":"Krilleke","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib437","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0049-3848(91)90113-B","article-title":"Development and validation of a size exclusion chromatography method for determination of molecular masses and molecular mass distribution in low molecular weight heparin","volume":"64","author":"Kristensen","year":"1991","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib438","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/cncr.22892","article-title":"A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications","volume":"110","author":"Kuderer","year":"2007","journal-title":"Cancer"},{"issue":"Suppl 2","key":"10.1124\/pr.115.011247_bib439","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S0049-3848(14)50021-7","article-title":"Guidelines for treatment and prevention of venous thromboembolism among patients with cancer","volume":"133","author":"Kuderer","year":"2014","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib440","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/glycob\/cwu069","article-title":"NMR characterization of the binding properties and conformation of glycosaminoglycans interacting with interleukin-10","volume":"24","author":"K\u00fcnze","year":"2014","journal-title":"Glycobiology"},{"issue":"Suppl 2","key":"10.1124\/pr.115.011247_bib441","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0049-3848(14)50003-5","article-title":"Predicting recurrent venous thromboembolism in cancer: is it possible?","volume":"133","author":"Kyrle","year":"2014","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib442","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0049-3848(84)90284-6","article-title":"Heparin inhibition of polymorphonuclear leukocyte activation in vitro. A possible pharmacological approach to granulocyte-mediated vascular damage","volume":"35","author":"Laghi Pasini","year":"1984","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib443","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1021\/ja201753e","article-title":"13C-labeled heparan sulfate analogue as a tool to study protein\/heparan sulfate interactions by NMR spectroscopy: application to the CXCL12\u03b1 chemokine","volume":"133","author":"Laguri","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.115.011247_bib444","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0006-291X(76)90558-1","article-title":"The separation of active and inactive forms of heparin","volume":"69","author":"Lam","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.115.011247_bib445","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.injury.2014.10.013","article-title":"The role of pleiotrophin in bone repair","volume":"45","author":"Lamprou","year":"2014","journal-title":"Injury"},{"key":"10.1124\/pr.115.011247_bib446","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0049-3848(78)90297-9","article-title":"Anticoagulant activities of four unfractionated and fractionated heparins","volume":"12","author":"Lane","year":"1978","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib447","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jmb.2009.01.028","article-title":"The critical role of hinge-region expulsion in the induced-fit heparin binding mechanism of antithrombin","volume":"386","author":"Langdown","year":"2009","journal-title":"J Mol Biol"},{"key":"10.1124\/pr.115.011247_bib448","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000356513","article-title":"The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H?","volume":"6","author":"Langford-Smith","year":"2014","journal-title":"J Innate Immun"},{"key":"10.1124\/pr.115.011247_bib449","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.20","article-title":"Enhancement of transdermal delivery of heparin by various physical and chemical enhancement techniques","volume":"26","author":"Lanke","year":"2009","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1124\/pr.115.011247_bib450","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1398-9995.1987.tb00393.x","article-title":"Heparin-like anticoagulants in asthma","volume":"42","author":"Lasser","year":"1987","journal-title":"Allergy"},{"key":"10.1124\/pr.115.011247_bib451","doi-asserted-by":"crossref","first-page":"22294","DOI":"10.1074\/jbc.M311224200","article-title":"Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo","volume":"279","author":"Lau","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib452","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/07357900802647136","article-title":"Heparins attenuate cancer metastasis: are selectins the link?","volume":"27","author":"Laubli","year":"2009","journal-title":"Cancer Invest"},{"issue":"8","key":"10.1124\/pr.115.011247_bib1011","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1183\/09031936.93.04081004","article-title":"Prevention of leucocyte elastase-induced emphysema in mice by heparin fragments","volume":"4","author":"Laufma","year":"1991","journal-title":"Eur Respir J"},{"key":"10.1124\/pr.115.011247_bib958","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0092-8674(91)90393-D","article-title":"Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins","volume":"65","author":"Lawrence","year":"1991","journal-title":"Cell"},{"key":"10.1124\/pr.115.011247_bib453","doi-asserted-by":"crossref","first-page":"33674","DOI":"10.1074\/jbc.M804288200","article-title":"Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling","volume":"283","author":"Lawrence","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib454","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/jth.12675","article-title":"Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study","volume":"12","author":"Lazo-Langner","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib455","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/MCP.0b013e3283061191","article-title":"Heparin-induced osteoporosis and pregnancy","volume":"14","author":"Le Templier","year":"2008","journal-title":"Curr Opin Pulm Med"},{"key":"10.1124\/pr.115.011247_bib456","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032421","article-title":"Differential contribution of the repeats to heparin binding of HBHA, a major adhesin of Mycobacterium tuberculosis","volume":"7","author":"Lebrun","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011247_bib457","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archinte.158.8.873","article-title":"The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty","volume":"158","author":"Leclerc","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1124\/pr.115.011247_bib458","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.1992.tb08176.x","article-title":"Specific binding between human neutrophils and heparin","volume":"81","author":"Leculier","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1124\/pr.115.011247_bib459","doi-asserted-by":"crossref","first-page":"42732","DOI":"10.1074\/jbc.M405382200","article-title":"Heparan sulfate structure in mice with genetically modified heparan sulfate production","volume":"279","author":"Ledin","year":"2004","journal-title":"J Biol Chem"},{"issue":"Suppl 2","key":"10.1124\/pr.115.011247_bib460","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0049-3848(10)70004-9","article-title":"The roles of anticoagulants in patients with cancer","volume":"125","author":"Lee","year":"2010","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib461","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.115.011247_bib462","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1016\/j.biomaterials.2012.06.017","article-title":"The effect of controlled release of PDGF-BB from heparin-conjugated electrospun PCL\/gelatin scaffolds on cellular bioactivity and infiltration","volume":"33","author":"Lee","year":"2012","journal-title":"Biomaterials"},{"key":"10.1124\/pr.115.011247_bib463","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/jbm.a.35207","article-title":"Controlled release of BMP-2 using a heparin-conjugated carrier system reduces in vivo adipose tissue formation","volume":"103","author":"Lee","year":"2015","journal-title":"J Biomed Mater Res A"},{"key":"10.1124\/pr.115.011247_bib464","doi-asserted-by":"crossref","first-page":"9567","DOI":"10.1074\/jbc.M412398200","article-title":"Structural basis of citrate-dependent and heparan sulfate-mediated cell surface retention of cobra cardiotoxin A3","volume":"280","author":"Lee","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib465","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4269\/ajtmh.2011.10-0256","article-title":"Low anticoagulant heparin disrupts Plasmodium falciparum rosettes in fresh clinical isolates","volume":"84","author":"Leitgeb","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1124\/pr.115.011247_bib466","first-page":"1134","article-title":"Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies","volume":"108","author":"Lepercq","year":"2001","journal-title":"BJOG"},{"key":"10.1124\/pr.115.011247_bib467","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.bjp.0703099","article-title":"The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro","volume":"129","author":"Lever","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib468","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.bjp.0707298","article-title":"Size-fractionated heparins have differential effects on human neutrophil function in vitro","volume":"151","author":"Lever","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib469","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-3-642-23056-1_12","article-title":"Non-anticoagulant effects of heparin: an overview","volume":"207","author":"Lever","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pr.115.011247_bib470","doi-asserted-by":"crossref","first-page":"C1184","DOI":"10.1152\/ajpcell.00269.2013","article-title":"Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium","volume":"306","author":"Lever","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/pr.115.011247_bib471","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2009.12.015","article-title":"Locally available heparin modulates inflammatory cell recruitment in a manner independent of anticoagulant activity","volume":"630","author":"Lever","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib472","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1001\/archderm.1983.01650290040014","article-title":"Heparin-induced cutaneous necrosis unrelated to injection sites. A sign of potentially lethal complications","volume":"119","author":"Levine","year":"1983","journal-title":"Arch Dermatol"},{"key":"10.1124\/pr.115.011247_bib473","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-114-7-545","article-title":"Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin","volume":"114","author":"Levine","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1124\/pr.115.011247_bib474","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jsb.2008.12.002","article-title":"Heparin binding induces conformational changes in Adeno-associated virus serotype 2","volume":"165","author":"Levy","year":"2009","journal-title":"J Struct Biol"},{"key":"10.1124\/pr.115.011247_bib475","first-page":"H1667","article-title":"Sulfated polysaccharides inhibit leukocyte rolling in rabbit mesentery venules","volume":"260","author":"Ley","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.011247_bib476","doi-asserted-by":"crossref","first-page":"27673","DOI":"10.1074\/jbc.M110.118703","article-title":"Structure of pleiotrophin- and hepatocyte growth factor-binding sulfated hexasaccharide determined by biochemical and computational approaches","volume":"285","author":"Li","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib477","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1021\/ac403625a","article-title":"Method to detect contaminants in heparin using radical depolymerization and liquid chromatography-mass spectrometry","volume":"86","author":"Li","year":"2014","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib478","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1160\/TH09-02-0091","article-title":"Heparin, heparan sulfate and heparanase in inflammatory reactions","volume":"102","author":"Li","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib479","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1021\/ac302232c","article-title":"Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS","volume":"84","author":"Li","year":"2012","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib480","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/cc7949","article-title":"Unfractionated heparin and enoxaparin reduce high-stretch ventilation augmented lung injury: a prospective, controlled animal experiment","volume":"13","author":"Li","year":"2009","journal-title":"Crit Care"},{"key":"10.1124\/pr.115.011247_bib481","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1073\/pnas.0711055105","article-title":"Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex","volume":"105","author":"Li","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib1012","doi-asserted-by":"crossref","first-page":"36039","DOI":"10.1074\/jbc.M805974200","article-title":"The heparin binding site of protein C inhibitor is protease-dependent","volume":"283","author":"Li","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib482","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood-2012-03-415869","article-title":"Crystal structures of protease nexin-1 in complex with heparin and thrombin suggest a 2-step recognition mechanism","volume":"120","author":"Li","year":"2012","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib483","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nsmb811","article-title":"Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin","volume":"11","author":"Li","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/pr.115.011247_bib484","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.imbio.2014.06.005","article-title":"Unfractionated heparin suppresses lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human microvascular endothelial cells by blocking Kr\u00fcppel-like factor 5 and nuclear factor-\u03baB pathway","volume":"219","author":"Li","year":"2014","journal-title":"Immunobiology"},{"key":"10.1124\/pr.115.011247_bib485","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.actbio.2013.07.031","article-title":"Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications","volume":"10","author":"Liang","year":"2014","journal-title":"Acta Biomater"},{"key":"10.1124\/pr.115.011247_bib486","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/eji.1830200306","article-title":"Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity","volume":"20","author":"Lider","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1124\/pr.115.011247_bib487","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1093\/emboj\/20.20.5543","article-title":"Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor","volume":"20","author":"Lietha","year":"2001","journal-title":"EMBO J"},{"key":"10.1124\/pr.115.011247_bib488","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1042\/BJ20121622","article-title":"Structure-function analysis of full-length midkine reveals novel residues important for heparin binding and zebrafish embryogenesis","volume":"451","author":"Lim","year":"2013","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib489","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1097\/01.ASN.0000145014.80714.35","article-title":"Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials","volume":"15","author":"Lim","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.115.011247_bib490","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/0003-4819-144-9-200605020-00011","article-title":"Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency","volume":"144","author":"Lim","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1124\/pr.115.011247_bib491","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-4165(01)00117-9","article-title":"Antithrombin binding of low molecular weight heparins and inhibition of factor Xa","volume":"1526","author":"Lin","year":"2001","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"10.1124\/pr.115.011247_bib1013","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1073\/pnas.77.11.6551","article-title":"Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin","volume":"77","author":"Lindahl","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib493","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/joim.12061","article-title":"Pathophysiology of heparan sulphate: many diseases, few drugs","volume":"273","author":"Lindahl","year":"2013","journal-title":"J Intern Med"},{"key":"10.1124\/pr.115.011247_bib494","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1937-6448(09)76003-4","article-title":"Interactions between heparan sulfate and proteins-design and functional implications","volume":"276","author":"Lindahl","year":"2009","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1124\/pr.115.011247_bib495","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1021\/jm049812m","article-title":"Generation of \u201cneoheparin\u201d from E. coli K5 capsular polysaccharide","volume":"48","author":"Lindahl","year":"2005","journal-title":"J Med Chem"},{"issue":"Suppl 3","key":"10.1124\/pr.115.011247_bib496","first-page":"5","article-title":"Production and chemical processing of low molecular weight heparins","volume":"25","author":"Linhardt","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pr.115.011247_bib497","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1021\/bi00462a026","article-title":"Examination of the substrate specificity of heparin and heparan sulfate lyases","volume":"29","author":"Linhardt","year":"1990","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib498","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00402-014-1939-2","article-title":"Administration of enoxaparin 24\u00a0h after total knee arthroplasty: safer for bleeding and equally effective for deep venous thrombosis prevention","volume":"134","author":"Liu","year":"2014","journal-title":"Arch Orthop Trauma Surg"},{"key":"10.1124\/pr.115.011247_bib499","doi-asserted-by":"crossref","first-page":"33456","DOI":"10.1074\/jbc.M202034200","article-title":"Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D","volume":"277","author":"Liu","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib500","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1016\/j.actbio.2013.06.045","article-title":"Bilayered vascular grafts based on silk proteins","volume":"9","author":"Liu","year":"2013","journal-title":"Acta Biomater"},{"key":"10.1124\/pr.115.011247_bib501","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1160\/TH09-01-0064","article-title":"Heparins: process-related physico-chemical and compositional characteristics, fingerprints and impurities","volume":"102","author":"Liverani","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib502","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1021\/bi00321a001","article-title":"Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography","volume":"23","author":"Lobb","year":"1984","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib503","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1160\/TH07-04-0252","article-title":"Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia","volume":"99","author":"Lobo","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib504","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/cyto.1996.0142","article-title":"Human interleukin 4 is a glycosaminoglycan-binding protein","volume":"9","author":"Lortat-Jacob","year":"1997","journal-title":"Cytokine"},{"key":"10.1124\/pr.115.011247_bib505","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1073\/pnas.032497699","article-title":"Structural diversity of heparan sulfate binding domains in chemokines","volume":"99","author":"Lortat-Jacob","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib506","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1160\/TH05-05-0318","article-title":"Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides","volume":"94","author":"Ludwig","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib507","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1160\/TH06-04-0210","article-title":"Management of cutaneous type IV hypersensitivity reactions induced by heparin","volume":"96","author":"Ludwig","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib508","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.thromres.2012.01.017","article-title":"Pregnancy-related venous thromboembolism: risk and the effect of thromboprophylaxis","volume":"129","author":"Lussana","year":"2012","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib509","doi-asserted-by":"crossref","first-page":"18000","DOI":"10.1074\/jbc.272.29.18000","article-title":"The interaction of the transforming growth factor-betas with heparin\/heparan sulfate is isoform-specific","volume":"272","author":"Lyon","year":"1997","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1124\/pr.115.011247_bib1014","article-title":"Heparanase mediates renal dysfunction during early sepsis in mice","volume":"1","author":"Lygizos","year":"2013","journal-title":"Physiol Rep epub 2013"},{"key":"10.1124\/pr.115.011247_bib510","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/sj.bjp.0705848","article-title":"Heparin normalizes allergen-induced nitric oxide deficiency and airway hyperresponsiveness","volume":"142","author":"Maarsingh","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib511","doi-asserted-by":"crossref","first-page":"23898","DOI":"10.1016\/S0021-9258(20)80470-0","article-title":"Minimal sequence in heparin\/heparan sulfate required for binding of basic fibroblast growth factor","volume":"268","author":"Maccarana","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib512","doi-asserted-by":"crossref","first-page":"17804","DOI":"10.1074\/jbc.271.30.17804","article-title":"Domain structure of heparan sulfates from bovine organs","volume":"271","author":"Maccarana","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib513","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1378\/chest.125.5.1616","article-title":"Dosing practices and risk factors for bleeding in patients receiving enoxaparin for the treatment of an acute coronary syndrome","volume":"125","author":"Macie","year":"2004","journal-title":"Chest"},{"key":"10.1124\/pr.115.011247_bib514","doi-asserted-by":"crossref","first-page":"13140","DOI":"10.1002\/anie.201204459","article-title":"Site-specific identification of an a\u03b2 fibril-heparin interaction site by using solid-state NMR spectroscopy","volume":"51","author":"Madine","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pr.115.011247_bib515","article-title":"Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes","volume":"1","author":"Magee","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pr.115.011247_bib1015","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1074\/jbc.M604938200","article-title":"Cellular adhesion responses to the heparin-binding (Hepll) domainof fibronectin require heparan sulfate with specific properties","volume":"282","author":"Mahalingam","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib516","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)98760-0","article-title":"Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity","volume":"266","author":"Maimone","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib517","doi-asserted-by":"crossref","first-page":"14628","DOI":"10.1073\/pnas.1306939110","article-title":"Human \u03b1-L-iduronidase uses its own N-glycan as a substrate-binding and catalytic module","volume":"110","author":"Maita","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib518","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/pcmr.12287","article-title":"Heparin inhibits melanosome uptake and inflammatory response coupled with phagocytosis through blocking PI3k\/Akt and MEK\/ERK signaling pathways in human epidermal keratinocytes","volume":"27","author":"Makino-Okamura","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"issue":"Suppl 2","key":"10.1124\/pr.115.011247_bib519","first-page":"II24","article-title":"Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk","volume":"30","author":"Manoukian","year":"2007","journal-title":"Clin Cardiol"},{"key":"10.1124\/pr.115.011247_bib520","doi-asserted-by":"crossref","first-page":"34141","DOI":"10.1074\/jbc.M114.589630","article-title":"A liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase","volume":"289","author":"Mao","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib521","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.thromres.2007.06.015","article-title":"Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin","volume":"121","author":"Marchetti","year":"2008","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib522","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/jth.12871","article-title":"Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data","volume":"13","author":"Marcucci","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib523","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/jamp.2009.0780","article-title":"Safety and tolerability of inhaled heparin in idiopathic pulmonary fibrosis","volume":"23","author":"Markart","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1124\/pr.115.011247_bib524","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3810\/pgm.2014.11.2830","article-title":"Diagnosis, treatment, and prevention of venous thromboembolism in pregnancy","volume":"126","author":"Marshall","year":"2014","journal-title":"Postgrad Med"},{"key":"10.1124\/pr.115.011247_bib525","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib526","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood-2012-01-406207","article-title":"Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism","volume":"120","author":"Mart\u00ednez-Mart\u00ednez","year":"2012","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib527","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.thromres.2010.11.008","article-title":"Heparin affinity of factor VIIa: implications on the physiological inhibition by antithrombin and clearance of recombinant factor VIIa","volume":"127","author":"Mart\u00ednez-Mart\u00ednez","year":"2011","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib528","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0008-6215(97)10060-X","article-title":"Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation","volume":"306","author":"Maruyama","year":"1998","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib529","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.bbrc.2014.04.015","article-title":"A mutation in the heparin-binding site of noggin as a novel mechanism of proximal symphalangism and conductive hearing loss","volume":"447","author":"Masuda","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.115.011247_bib530","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00705-013-1831-3","article-title":"Structural requirements of glycosaminoglycans for their interaction with HIV-1 envelope glycoprotein gp120","volume":"159","author":"Matos","year":"2014","journal-title":"Arch Virol"},{"key":"10.1124\/pr.115.011247_bib531","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0038-1661157","article-title":"The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis","volume":"52","author":"Matzner","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib532","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jlb.51.6.519","article-title":"Subcellular localization of heparanase in human neutrophils","volume":"51","author":"Matzner","year":"1992","journal-title":"J Leukoc Biol"},{"key":"10.1124\/pr.115.011247_bib533","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1083\/jcb.109.1.441","article-title":"Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta\/alpha 2-macroglobulin inactive complex","volume":"109","author":"McCaffrey","year":"1989","journal-title":"J Cell Biol"},{"key":"10.1124\/pr.115.011247_bib534","article-title":"Production and titering of recombinant adeno-associated viral vectors","volume":"57","author":"McClure","year":"2011","journal-title":"J Vis Exp"},{"key":"10.1124\/pr.115.011247_bib535","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1021\/bi049751u","article-title":"Glycosaminoglycan disaccharide alters the dimer dissociation constant of the chemokine MIP-1 beta","volume":"43","author":"McCornack","year":"2004","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib536","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0022-2836(02)01382-7","article-title":"Structure of beta-antithrombin and the effect of glycosylation on antithrombin\u2019s heparin affinity and activity","volume":"326","author":"McCoy","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1124\/pr.115.011247_bib537","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114242","article-title":"Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from blood by heparin-functional hemoperfusion media","volume":"9","author":"McCrea","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011247_bib538","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpba.2009.09.009","article-title":"Broadening of 1H NMR signals in the spectra of heparin and OSCS by paramagnetic transition metal ions. The use of EDTA to sharpen the signals","volume":"51","author":"McEwen","year":"2010","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pr.115.011247_bib539","first-page":"65","article-title":"Identification and purity test of heparin by NMR - a summary of two years\u2019 experience at the Medical Products Agency","volume":"2010","author":"McEwen","year":"2010","journal-title":"Pharmeur Bio Sci Notes"},{"key":"10.1124\/pr.115.011247_bib540","first-page":"31","article-title":"Determination of oversulphated chondroitin sulphate and dermatan sulphate in unfractionated heparin by (1)H-NMR - collaborative study for quantification and analytical determination of LoD","volume":"2008","author":"McEwen","year":"2008","journal-title":"Pharmeur Bio"},{"key":"10.1124\/pr.115.011247_bib541","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jpba.2008.12.012","article-title":"Effect of Ca2+ on the 1H NMR chemical shift of the methyl signal of oversulphated chondroitin sulphate, a contaminant in heparin","volume":"49","author":"McEwen","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pr.115.011247_bib542","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1163\/156856208784909381","article-title":"Heparin-regulated delivery of osteoprotegerin promotes vascularization of implanted hydrogels","volume":"19","author":"McGonigle","year":"2008","journal-title":"J Biomater Sci Polym Ed"},{"key":"10.1124\/pr.115.011247_bib543","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1021\/bi971403n","article-title":"Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9 A","volume":"36","author":"McGrath","year":"1997","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib544","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/0091270009355158","article-title":"Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin","volume":"50","author":"McKee","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.115.011247_bib545","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1006\/bbrc.2000.3586","article-title":"Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member","volume":"276","author":"McKenzie","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.115.011247_bib546","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0707182","article-title":"Heparanase: a target for drug discovery in cancer and inflammation","volume":"151","author":"McKenzie","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib547","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1152\/ajplegacy.1916.41.2.250","article-title":"The thromboplastic action of cephalin","volume":"41","author":"McLean","year":"1916","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.115.011247_bib548","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ccc.2011.07.001","article-title":"Venous thromboembolism prophylaxis in critically ill patients","volume":"27","author":"McLeod","year":"2011","journal-title":"Crit Care Clin"},{"key":"10.1124\/pr.115.011247_bib549","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1074\/jbc.M112.423012","article-title":"Immobilization of heparan sulfate on electrospun meshes to support embryonic stem cell culture and differentiation","volume":"288","author":"Meade","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib550","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fncel.2014.00113","article-title":"The role of extracellular Tau in the spreading of neurofibrillary pathology","volume":"8","author":"Medina","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/pr.115.011247_bib551","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1160\/TH07-01-0040","article-title":"Chemokines as mediators of angiogenesis","volume":"97","author":"Mehrad","year":"2007","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"10.1124\/pr.115.011247_bib552","first-page":"81","article-title":"Heparin to pentasaccharide and beyond: the end is not in sight","volume":"30","author":"Messmore","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pr.115.011247_bib553","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00042737-200104000-00026","article-title":"Heparin therapy for ulcerative colitis? Effects and mechanisms","volume":"13","author":"Michell","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1124\/pr.115.011247_bib554","doi-asserted-by":"crossref","first-page":"25317","DOI":"10.1074\/jbc.274.36.25317","article-title":"Heparin dodecasaccharide binding to platelet factor-4 and growth-related protein-alpha. Induction of a partially folded state and implications for heparin-induced thrombocytopenia","volume":"274","author":"Mikhailov","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib555","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/CCM.0b013e3182a645e5","article-title":"Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review","volume":"42","author":"Miller","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1124\/pr.115.011247_bib556","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/BCR.0b013e318198a268","article-title":"Influence of nebulized unfractionated heparin and N-acetylcysteine in acute lung injury after smoke inhalation injury","volume":"30","author":"Miller","year":"2009","journal-title":"J Burn Care Res"},{"key":"10.1124\/pr.115.011247_bib960","first-page":"17","article-title":"Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines","volume":"12","author":"Miller","year":"1992","journal-title":"Crit Rev immunol"},{"key":"10.1124\/pr.115.011247_bib557","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/sj.onc.1206146","article-title":"Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers","volume":"22","author":"Miyamoto","year":"2003","journal-title":"Oncogene"},{"key":"10.1124\/pr.115.011247_bib558","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/glycob\/cwt062","article-title":"Investigation of lysine side chain interactions of interleukin-8 with heparin and other glycosaminoglycans studied by a methylation-NMR approach","volume":"23","author":"M\u00f6bius","year":"2013","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib559","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10719-007-9081-9","article-title":"The structural plasticity of heparan sulfate NA-domains and hence their role in mediating multivalent interactions is confirmed by high-accuracy (15)N-NMR relaxation studies","volume":"25","author":"Mobli","year":"2008","journal-title":"Glycoconj J"},{"key":"10.1124\/pr.115.011247_bib560","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0049-3848(80)90148-6","article-title":"Quantitative removal of heparin from plasma and other aqueous solutions by affinity adsorption on poly(L-lysine)-sepharose 4B","volume":"20","author":"Mohammad","year":"1980","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib561","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.sbi.2005.09.002","article-title":"A protein canyon in the FGF-FGF receptor dimer selects from an \u00e0 la carte menu of heparan sulfate motifs","volume":"15","author":"Mohammadi","year":"2005","journal-title":"Curr Opin Struct Biol"},{"key":"10.1124\/pr.115.011247_bib562","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1642376","article-title":"Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin","volume":"71","author":"Monreal","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib563","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00558513","article-title":"Adverse effects of three different forms of heparin therapy: thrombocytopenia, increased transaminases, and hyperkalaemia","volume":"37","author":"Monreal","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/pr.115.011247_bib564","doi-asserted-by":"crossref","first-page":"45185","DOI":"10.1074\/jbc.M405013200","article-title":"Structural analysis of the sulfotransferase (3-o-sulfotransferase isoform 3) involved in the biosynthesis of an entry receptor for herpes simplex virus 1","volume":"279","author":"Moon","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib565","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1073\/pnas.1117923109","article-title":"Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin","volume":"109","author":"Moon","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib566","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1021\/bi401376u","article-title":"The novel heparin-binding motif in decorin-binding protein A from strain B31 of Borrelia burgdorferi explains the higher binding affinity","volume":"52","author":"Morgan","year":"2013","journal-title":"Biochemistry"},{"issue":"6","key":"10.1124\/pr.115.011247_bib961","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127032","article-title":"The role of heparanase in pulmonary cell recruitmen in response to allergic, but not non-allergic stimuli","volume":"10","author":"Morris","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011247_bib567","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jama.1994.03510270069042","article-title":"Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis","volume":"271","author":"Moser","year":"1994","journal-title":"JAMA"},{"key":"10.1124\/pr.115.011247_bib568","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048632","article-title":"On the specificity of heparin\/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different","volume":"7","author":"Mosier","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011247_bib569","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1164\/ajrccm\/139.3.801","article-title":"Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro","volume":"139","author":"Motojima","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/pr.115.011247_bib570","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/ci500115j","article-title":"Docking server for the identification of heparin binding sites on proteins","volume":"54","author":"Mottarella","year":"2014","journal-title":"J Chem Inf Model"},{"key":"10.1124\/pr.115.011247_bib571","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jpba.2010.09.011","article-title":"Heparin sodium compliance to the new proposed USP monograph: elucidation of a minor structural modification responsible for a process dependent 2.10 ppm NMR signal","volume":"54","author":"Mourier","year":"2011","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pr.115.011247_bib572","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jpba.2012.04.015","article-title":"Heparin sodium compliance to USP monograph: structural elucidation of an atypical 2.18 ppm NMR signal","volume":"67-68","author":"Mourier","year":"2012","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pr.115.011247_bib573","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ab.2004.06.020","article-title":"Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phases","volume":"332","author":"Mourier","year":"2004","journal-title":"Anal Biochem"},{"key":"10.1124\/pr.115.011247_bib574","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-60761-803-4_3","article-title":"Heparin and low-molecular weight heparins in thrombosis and beyond","volume":"663","author":"Mousa","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pr.115.011247_bib575","first-page":"133","article-title":"Tissue factor pathway inhibitor in thrombosis and beyond","volume":"93","author":"Mousa","year":"2004","journal-title":"Methods Mol Med"},{"key":"10.1124\/pr.115.011247_bib576","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1160\/TH06-05-0289","article-title":"Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin","volume":"96","author":"Mousa","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib577","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1182\/blood.V88.4.1314.bloodjournal8841314","article-title":"Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo","volume":"88","author":"Muir","year":"1996","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib578","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood.V89.9.3236","article-title":"A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats","volume":"89","author":"Muir","year":"1997","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib579","first-page":"721","article-title":"The interaction between heparin and polylysine: a circular dichroism and molecular modelling study","volume":"29","author":"Mulloy","year":"1996","journal-title":"Braz J Med Biol Res"},{"key":"10.1124\/pr.115.011247_bib580","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1042\/bj2930849","article-title":"N.M.R. and molecular-modelling studies of the solution conformation of heparin","volume":"293","author":"Mulloy","year":"1993","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib581","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/glycob\/10.11.1147","article-title":"Conformation and dynamics of heparin and heparan sulfate","volume":"10","author":"Mulloy","year":"2000","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib582","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0008-6215(00)90968-6","article-title":"The effect of variation of substitution on the solution conformation of heparin: a spectroscopic and molecular modelling study","volume":"255","author":"Mulloy","year":"1994","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib1016","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/08927020701784754","article-title":"Application of drug discovery software to the identification of heparin-binding sites on protein surfaces a computational survey of the 4-helix cytokines","volume":"34","author":"Mulloy","year":"2008","journal-title":"Molecular Stimulations"},{"key":"10.1124\/pr.115.011247_bib583","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0038-1656031","article-title":"Molecular weight measurements of low molecular weight heparins by gel permeation chromatography","volume":"77","author":"Mulloy","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib584","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1007\/s00216-014-7940-3","article-title":"USP compendial methods for analysis of heparin: chromatographic determination of molecular weight distributions for heparin sodium","volume":"406","author":"Mulloy","year":"2014","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pr.115.011247_bib585","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4939-1714-3_11","article-title":"Chromatographic molecular weight measurements for heparin, its fragments and fractions, and other glycosaminoglycans","volume":"1229","author":"Mulloy","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pr.115.011247_bib1017","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.4049\/jimmunol.165.10.5671","article-title":"Characterization of the heparin-binding properties of IL-6","volume":"165","author":"Mummery","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011247_bib586","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/glycob\/cwu071","article-title":"Importance of the polarity of the glycosaminoglycan chain on the interaction with FGF-1","volume":"24","author":"Mu\u00f1oz-Garc\u00eda","year":"2014","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib962","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1002\/pmic.200800042","article-title":"Glycosaminoglycan-binding cytokines as tumor markers","volume":"8","author":"Muramatsu","year":"2008","journal-title":"Proteomics"},{"key":"10.1124\/pr.115.011247_bib587","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0140-6736(93)90485-Y","article-title":"Disruption of sulphated glycosaminoglycans in intestinal inflammation","volume":"341","author":"Murch","year":"1993","journal-title":"Lancet"},{"key":"10.1124\/pr.115.011247_bib1018","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1074\/jbc.M608796200","article-title":"Structural and functional basis of CXCL12 (stromal cell-derived factor 1 alpha) binding to heparin","volume":"282","author":"Murphy","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib588","doi-asserted-by":"crossref","first-page":"27239","DOI":"10.1074\/jbc.M401774200","article-title":"A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase","volume":"279","author":"Murphy","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib589","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2174\/1381612043452758","article-title":"Heparins and heparinoids: occurrence, structure and mechanism of antithrombotic and hemorrhagic activities","volume":"10","author":"Nader","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pr.115.011247_bib590","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1074\/jbc.M111.290262","article-title":"Organ-specific sulfation patterns of heparan sulfate generated by extracellular sulfatases Sulf1 and Sulf2 in mice","volume":"287","author":"Nagamine","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib591","doi-asserted-by":"crossref","first-page":"12103","DOI":"10.1074\/jbc.M414217200","article-title":"Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting","volume":"280","author":"Naggi","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib592","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/glycob\/8.5.509","article-title":"Further characterization of the binding of human recombinant interleukin 2 to heparin and identification of putative binding sites","volume":"8","author":"Najjam","year":"1998","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib593","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jcb.240360207","article-title":"Heparanases and tumor metastasis","volume":"36","author":"Nakajima","year":"1988","journal-title":"J Cell Biochem"},{"key":"10.1124\/pr.115.011247_bib594","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.toxicon.2014.05.003","article-title":"Discovery of a novel vascular endothelial growth factor (VEGF) with no affinity to heparin in Gloydius tsushimaensis venom","volume":"86","author":"Nakamura","year":"2014","journal-title":"Toxicon"},{"key":"10.1124\/pr.115.011247_bib595","doi-asserted-by":"crossref","first-page":"26418","DOI":"10.1074\/jbc.M111.251140","article-title":"Sulfated glycosaminoglycans are required for specific and sensitive fibroblast growth factor (FGF) 19 signaling via FGF receptor 4 and betaKlotho","volume":"286","author":"Nakamura","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib596","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.saa.2009.08.032","article-title":"A study of interaction of cationic dyes with anionic polyelectrolytes","volume":"75","author":"Nandini","year":"2010","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1124\/pr.115.011247_bib597","first-page":"185","article-title":"Low-dose heparin inhibits acute graft versus host disease in mice","volume":"12","author":"Naparstek","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1124\/pr.115.011247_bib598","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10529-011-0840-0","article-title":"Removing human immunodeficiency virus (HIV) from human blood using immobilized heparin","volume":"34","author":"Nassar","year":"2012","journal-title":"Biotechnol Lett"},{"key":"10.1124\/pr.115.011247_bib599","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood.V82.11.3253.3253","article-title":"Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation","volume":"82","author":"Nelson","year":"1993","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib600","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1021\/ac401318q","article-title":"High-throughput differentiation of heparin from other glycosaminoglycans by pyrolysis mass spectrometry","volume":"85","author":"Nemes","year":"2013","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib601","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-156-10-201205150-00421","article-title":"Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis","volume":"156","author":"Neumann","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1124\/pr.115.011247_bib602","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jps.2600780205","article-title":"Monitoring the purity of pharmaceutical heparin preparations by high-field 1H-nuclear magnetic resonance spectroscopy","volume":"78","author":"Neville","year":"1989","journal-title":"J Pharm Sci"},{"key":"10.1124\/pr.115.011247_bib603","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-62703-339-8_21","article-title":"Protamine titration","volume":"992","author":"Newall","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pr.115.011247_bib604","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1055\/s-0038-1646302","article-title":"A convenient method for molecular mass determination of heparin","volume":"68","author":"Nielsen","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib605","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.critrevonc.2006.07.007","article-title":"Mechanisms of heparin induced anti-cancer activity in experimental cancer models","volume":"61","author":"Niers","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1124\/pr.115.011247_bib606","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/cbic.201300313","article-title":"Heparin modulates the mitogenic activity of fibroblast growth factor by inducing dimerization of its receptor. a 3D view by using NMR","volume":"14","author":"Nieto","year":"2013","journal-title":"ChemBioChem"},{"key":"10.1124\/pr.115.011247_bib607","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1016\/j.biomaterials.2014.01.033","article-title":"Heparin-modified gelatin scaffolds for human corneal endothelial cell transplantation","volume":"35","author":"Niu","year":"2014","journal-title":"Biomaterials"},{"issue":"Suppl 1","key":"10.1124\/pr.115.011247_bib608","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/S0049-3848(12)70029-4","article-title":"Low-molecular-weight heparin and survival in lung cancer","volume":"129","author":"Noble","year":"2012","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib609","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000024284","article-title":"Heparin, derived from the mast cells of human lungs is responsible for the generation of kinins in allergic reactions due to the activation of the contact system","volume":"120","author":"Noga","year":"1999","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1124\/pr.115.011247_bib610","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1089\/ten.tea.2014.0182","article-title":"A dual delivery of substance P and bone morphogenetic protein-2 for mesenchymal stem cell recruitment and bone regeneration","volume":"21","author":"Noh","year":"2015","journal-title":"Tissue Eng Part A"},{"key":"10.1124\/pr.115.011247_bib611","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.str.2013.06.005","article-title":"Structure of protein related to Dan and Cerberus: insights into the mechanism of bone morphogenetic protein antagonism","volume":"21","author":"Nolan","year":"2013","journal-title":"Structure"},{"key":"10.1124\/pr.115.011247_bib612","doi-asserted-by":"crossref","first-page":"8664","DOI":"10.1002\/chem.200601103","article-title":"Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions","volume":"12","author":"Noti","year":"2006","journal-title":"Chemistry"},{"key":"10.1124\/pr.115.011247_bib613","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.virol.2008.11.037","article-title":"Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex","volume":"385","author":"O\u2019Donnell","year":"2009","journal-title":"Virology"},{"key":"10.1124\/pr.115.011247_bib614","doi-asserted-by":"crossref","first-page":"50267","DOI":"10.1074\/jbc.M408774200","article-title":"The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism","volume":"279","author":"O\u2019Keeffe","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib615","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ab.2007.05.016","article-title":"Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography\/turbo ionspray ionization tandem mass spectrometry","volume":"368","author":"Oguma","year":"2007","journal-title":"Anal Biochem"},{"key":"10.1124\/pr.115.011247_bib616","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.bjp.0702046","article-title":"Inhibition of serum and transforming growth factor beta (TGF-beta1)-induced DNA synthesis in confluent airway smooth muscle by heparin","volume":"125","author":"Okona-Mensah","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib617","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.biochi.2010.05.011","article-title":"Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors","volume":"92","author":"Olson","year":"2010","journal-title":"Biochimie"},{"key":"10.1124\/pr.115.011247_bib618","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1160\/TH04-06-0384","article-title":"Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin","volume":"92","author":"Olson","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib619","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/BCR.0b013e3181599b9b","article-title":"A systematic review of heparin to treat burn injury","volume":"28","author":"Oremus","year":"2007","journal-title":"J Burn Care Res"},{"key":"10.1124\/pr.115.011247_bib620","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-3-642-23056-1_18","article-title":"Semi-synthetic heparinoids","volume":"207","author":"Oreste","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pr.115.011247_bib621","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/molehr\/gag001","article-title":"Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term","volume":"9","author":"Osman","year":"2003","journal-title":"Mol Hum Reprod"},{"issue":"6","key":"10.1124\/pr.115.011247_bib971","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9343(99)80017-5","article-title":"Heparin-induced aldosterone suppression and hyperkalemia","volume":"98","author":"Oster","year":"1995","journal-title":"Am J Med"},{"key":"10.1124\/pr.115.011247_bib622","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1074\/jbc.M108540200","article-title":"Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes","volume":"277","author":"Ostrovsky","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib623","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0140-6736(91)90289-2","article-title":"One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists","volume":"337","author":"Page","year":"1991","journal-title":"Lancet"},{"key":"10.1124\/pr.115.011247_bib624","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-3-642-23056-1_11","article-title":"Neutralization of heparin activity","volume":"207","author":"Pai","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pr.115.011247_bib625","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1074\/jbc.M109151200","article-title":"Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients","volume":"277","author":"Paine-Saunders","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib1019","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2011.10.048","article-title":"Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: in vitro and in vivo evaluation","volume":"422","author":"Paliwa","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1124\/pr.115.011247_bib626","doi-asserted-by":"crossref","first-page":"28284","DOI":"10.1074\/jbc.M114.572297","article-title":"Fucosylated chondroitin sulfates from the body wall of the sea cucumber Holothuria forskali: conformation, selectin binding, and biological activity","volume":"289","author":"Panagos","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib627","first-page":"176","article-title":"Therapies for human prion diseases","volume":"2","author":"Panegyres","year":"2013","journal-title":"Am J Neurodegener Dis"},{"key":"10.1124\/pr.115.011247_bib628","first-page":"M99","article-title":"Heparanase: a key enzyme involved in cell invasion","volume":"1471","author":"Parish","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.115.011247_bib629","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/mp900319k","article-title":"Anticoagulant efficacy of solid oral formulations containing a new heparin derivative","volume":"7","author":"Park","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.115.011247_bib630","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1021\/bm401787u","article-title":"Macro\/Nano-gel composite as an injectable and bioactive bulking material for the treatment of urinary incontinence","volume":"15","author":"Park","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1124\/pr.115.011247_bib631","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1008154326954","article-title":"Micropattern-immobilization of heparin to regulate cell growth with fibroblast growth factor","volume":"33","author":"Park","year":"2000","journal-title":"Cytotechnology"},{"key":"10.1124\/pr.115.011247_bib632","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1021\/jm051221o","article-title":"Heparin derivatives as inhibitors of BACE-1, the Alzheimer\u2019s beta-secretase, with reduced activity against factor Xa and other proteases","volume":"49","author":"Patey","year":"2006","journal-title":"J Med Chem"},{"key":"10.1124\/pr.115.011247_bib633","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000113701","article-title":"Engineered heparins: novel beta-secretase inhibitors as potential Alzheimer\u2019s disease therapeutics","volume":"5","author":"Patey","year":"2008","journal-title":"Neurodegener Dis"},{"key":"10.1124\/pr.115.011247_bib634","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.1991.tb00618.x","article-title":"Hair growth inhibition by heparin in mice: a model system for studying the modulation of epithelial cell growth by glycosaminoglycans?","volume":"124","author":"Paus","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1124\/pr.115.011247_bib635","doi-asserted-by":"crossref","first-page":"27848","DOI":"10.1074\/jbc.273.43.27848","article-title":"Highly sulfated dermatan sulfates from Ascidians. Structure versus anticoagulant activity of these glycosaminoglycans","volume":"273","author":"Pav\u00e3o","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib636","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00249-003-0316-9","article-title":"Conformation of heparin studied with macromolecular hydrodynamic methods and X-ray scattering","volume":"32","author":"Pavlov","year":"2003","journal-title":"Eur Biophys J"},{"key":"10.1124\/pr.115.011247_bib637","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.4049\/jimmunol.177.7.4861","article-title":"Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells","volume":"177","author":"P\u00e9gorier","year":"2006","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011247_bib638","doi-asserted-by":"crossref","first-page":"12187","DOI":"10.1021\/bi991046b","article-title":"Mechanism by which heparin proteoglycan modulates mast cell chymase activity","volume":"38","author":"Pejler","year":"1999","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib639","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0959-440X(00)00258-X","article-title":"Role of heparan sulfate in fibroblast growth factor signalling: a structural view","volume":"11","author":"Pellegrini","year":"2001","journal-title":"Curr Opin Struct Biol"},{"key":"10.1124\/pr.115.011247_bib640","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/35039551","article-title":"Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin","volume":"407","author":"Pellegrini","year":"2000","journal-title":"Nature"},{"key":"10.1124\/pr.115.011247_bib641","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/32703","article-title":"Human beta-tryptase is a ring-like tetramer with active sites facing a central pore","volume":"392","author":"Pereira","year":"1998","journal-title":"Nature"},{"key":"10.1124\/pr.115.011247_bib642","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.carres.2010.05.026","article-title":"Conformational properties of glucose-based disaccharides investigated using molecular dynamics simulations with local elevation umbrella sampling","volume":"345","author":"Peri\u0107-Hassler","year":"2010","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib643","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fimmu.2014.00126","article-title":"Molecular interactions between complement factor H and its heparin and heparan sulfate ligands","volume":"5","author":"Perkins","year":"2014","journal-title":"Front Immunol"},{"key":"10.1124\/pr.115.011247_bib644","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-4419-5635-4_3","article-title":"Multiple interactions of complement Factor H with its ligands in solution: a progress report","volume":"703","author":"Perkins","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pr.115.011247_bib645","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1139\/v70-376","article-title":"220 MHz spectra of heparin, chondroitins, and other mucopolysaccharides","volume":"48","author":"Perlin","year":"1970","journal-title":"Can J Chem"},{"key":"10.1124\/pr.115.011247_bib646","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/01.CIR.100.14.1533","article-title":"Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b\/CD18)","volume":"100","author":"Peter","year":"1999","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011247_bib647","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0300-9084(03)00078-6","article-title":"1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site","volume":"85","author":"Petitou","year":"2003","journal-title":"Biochimie"},{"key":"10.1124\/pr.115.011247_bib648","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/18877","article-title":"Synthesis of thrombin-inhibiting heparin mimetics without side effects","volume":"398","author":"Petitou","year":"1999","journal-title":"Nature"},{"key":"10.1124\/pr.115.011247_bib649","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1160\/TH09-01-0063","article-title":"From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile","volume":"102","author":"Petitou","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib650","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0037-1612970","article-title":"Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin","volume":"87","author":"Pettil\u00e4","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib651","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1055\/s-0038-1650660","article-title":"Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes","volume":"76","author":"Piccardoni","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib652","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1128\/AAC.00359-08","article-title":"Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide","volume":"52","author":"Pinna","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/pr.115.011247_bib653","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1182\/blood-2004-06-2282","article-title":"Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation","volume":"105","author":"Pitchford","year":"2005","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib654","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1067\/mai.2003.1514","article-title":"Platelets are essential for leukocyte recruitment in allergic inflammation","volume":"112","author":"Pitchford","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/pr.115.011247_bib655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110055","article-title":"Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography","volume":"9","author":"Platonova","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011247_bib656","doi-asserted-by":"crossref","first-page":"25143","DOI":"10.1074\/jbc.M113.492579","article-title":"Molecular basis of glycosaminoglycan heparin binding to the chemokine CXCL1 dimer","volume":"288","author":"Poluri","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib657","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.bbagen.2012.08.022","article-title":"Fucanomics and galactanomics: current status in drug discovery, mechanisms of action and role of the well-defined structures","volume":"1820","author":"Pomin","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.115.011247_bib658","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/glycob\/cwu065","article-title":"Biological findings from the recent NMR-based studies of glycosaminoglycan-protein interactions","volume":"24","author":"Pomin","year":"2014","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib659","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.thromres.2014.03.036","article-title":"Subcutaneous enoxaparin for therapeutic anticoagulation in hemodialysis patients","volume":"133","author":"Pon","year":"2014","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib660","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2180-8-75","article-title":"Characterization of two heparan sulphate-binding sites in the mycobacterial adhesin Hlp","volume":"8","author":"Portugal","year":"2008","journal-title":"BMC Microbiol"},{"key":"10.1124\/pr.115.011247_bib661","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood.V97.10.3300","article-title":"Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia","volume":"97","author":"Pouplard","year":"2001","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib662","doi-asserted-by":"crossref","first-page":"17R","DOI":"10.1093\/glycob\/cwh051","article-title":"Interactions of heparin\/heparan sulfate with proteins: appraisal of structural factors and experimental approaches","volume":"14","author":"Powell","year":"2004","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib663","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0140-6736(92)91054-C","article-title":"Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis","volume":"339","author":"Prandoni","year":"1992","journal-title":"Lancet"},{"key":"10.1124\/pr.115.011247_bib664","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib665","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0035-1544161","article-title":"The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation","volume":"41","author":"Prandoni","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pr.115.011247_bib964","doi-asserted-by":"crossref","unstructured":"Preston RA, Hirsh MJ, Oster MD, Oster HR (1998) University of Miami division of clinical pharmacology therapeutic rounds: Drug-induced hyperkalemia 5(2):125\u201332.","DOI":"10.1097\/00045391-199803000-00013"},{"key":"10.1124\/pr.115.011247_bib666","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1242\/jcs.058321","article-title":"The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release","volume":"123","author":"Prince","year":"2010","journal-title":"J Cell Sci"},{"key":"10.1124\/pr.115.011247_bib667","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1084\/jem.20071069","article-title":"Structural basis for complement factor H linked age-related macular degeneration","volume":"204","author":"Prosser","year":"2007","journal-title":"J Exp Med"},{"key":"10.1124\/pr.115.011247_bib668","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.acvd.2012.04.002","article-title":"Comparison of bleeding complications and 3-year survival with low-molecular-weight heparin versus unfractionated heparin for acute myocardial infarction: the FAST-MI registry","volume":"105","author":"Puymirat","year":"2012","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1124\/pr.115.011247_bib669","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1074\/jbc.M114.602201","article-title":"Structural and functional study of D-glucuronyl C5-epimerase","volume":"290","author":"Qin","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib670","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7326\/0003-4819-140-3-200402030-00008","article-title":"Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials","volume":"140","author":"Quinlan","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1124\/pr.115.011247_bib671","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jcrc.2005.09.009","article-title":"Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency","volume":"20","author":"Rabbat","year":"2005","journal-title":"J Crit Care"},{"key":"10.1124\/pr.115.011247_bib672","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jss.2010.06.036","article-title":"Heparin-binding EGF-like growth factor promotes intestinal anastomotic healing","volume":"171","author":"Radulescu","year":"2011","journal-title":"J Surg Res"},{"key":"10.1124\/pr.115.011247_bib963","article-title":"Heparin inhibits leukocyte diapedesis via inhibition of platelet activation","author":"Riffo-Vasquez","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/pr.115.011247_bib673","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1021\/jm060092o","article-title":"Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin\/heparan sulfate sequence(s)","volume":"49","author":"Raghuraman","year":"2006","journal-title":"J Med Chem"},{"key":"10.1124\/pr.115.011247_bib674","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1016\/j.bmcl.2007.08.074","article-title":"Novel heparin\/heparan sulfate mimics as inhibitors of HGF\/SF-induced MET activation","volume":"17","author":"Raiber","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pr.115.011247_bib675","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbagen.2011.10.008","article-title":"Potentiation of C1-esterase inhibitor by heparin and interactions with C1s protease as assessed by surface plasmon resonance","volume":"1820","author":"Rajabi","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.115.011247_bib676","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1021\/nl0613555","article-title":"Heparin binding nanostructures to promote growth of blood vessels","volume":"6","author":"Rajangam","year":"2006","journal-title":"Nano Lett"},{"key":"10.1124\/pr.115.011247_bib677","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.thromres.2006.10.025","article-title":"The effects of heparin and low molecular weight heparins on bone","volume":"122","author":"Rajgopal","year":"2008","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib678","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/clinchem\/44.3.606","article-title":"Improved protamine-sensitive membrane electrode for monitoring heparin concentrations in whole blood via protamine titration","volume":"44","author":"Ramamurthy","year":"1998","journal-title":"Clin Chem"},{"key":"10.1124\/pr.115.011247_bib679","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/abio.1998.2947","article-title":"Determination of low-molecular-weight heparins and their binding to protamine and a protamine analog using polyion-sensitive membrane electrodes","volume":"266","author":"Ramamurthy","year":"1999","journal-title":"Anal Biochem"},{"key":"10.1124\/pr.115.011247_bib680","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0885-4505(91)90018-G","article-title":"Influence of heparins on inositol 1,4,5-trisphosphate-induced calcium mobilization in permeabilized human platelets","volume":"45","author":"Rao","year":"1991","journal-title":"Biochem Med Metab Biol"},{"key":"10.1124\/pr.115.011247_bib681","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1164\/ajrccm\/142.2.407","article-title":"Sulfated polysaccharides prevent human leukocyte elastase-induced acute lung injury and emphysema in hamsters","volume":"142","author":"Rao","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/pr.115.011247_bib682","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/blood-2004-04-1544","article-title":"Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia","volume":"105","author":"Rauova","year":"2005","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib1021","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jconrel.2008.03.013","article-title":"Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation","volume":"128","author":"Rawat","year":"2008","journal-title":"J Control Release"},{"key":"10.1124\/pr.115.011247_bib683","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1042\/bj2520515","article-title":"Inhibition of leucocyte elastase by heparin and its derivatives","volume":"252","author":"Redini","year":"1988","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib684","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/00365515409134865","article-title":"The titration of heparin with protamine","volume":"6","author":"Refn","year":"1954","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1124\/pr.115.011247_bib685","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","article-title":"ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)","volume":"32","author":"Regitz-Zagrosek","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1124\/pr.115.011247_bib686","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.biomaterials.2013.12.001","article-title":"Implantable controlled release devices for BMP-7 delivery and suppression of glioblastoma initiating cells","volume":"35","author":"Reguera-Nu\u00f1ez","year":"2014","journal-title":"Biomaterials"},{"key":"10.1124\/pr.115.011247_bib687","first-page":"4856","article-title":"Soluble amyloid-\u03b2 precursor protein binds its cell surface receptor in a cooperative fashion with glypican and syndecan proteoglycans","volume":"126","author":"Reinhard","year":"2013","journal-title":"J Cell Sci"},{"key":"10.1124\/pr.115.011247_bib688","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/ATVBAHA.111.242818","article-title":"Mechanistic view of risk factors for venous thromboembolism","volume":"32","author":"Reitsma","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.115.011247_bib689","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bbapap.2009.01.001","article-title":"A biophysical insight into the RANTES-glycosaminoglycan interaction","volume":"1794","author":"Rek","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.115.011247_bib690","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1074\/jbc.271.8.4289","article-title":"Structure-function analysis of P-selectin-sialyl LewisX binding interactions. Mutagenic alteration of ligand binding specificity","volume":"271","author":"Revelle","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib691","doi-asserted-by":"crossref","first-page":"12083","DOI":"10.1021\/bi0011126","article-title":"Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies","volume":"39","author":"Rezaie","year":"2000","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib692","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1073\/pnas.95.8.4176","article-title":"Mass spectrometric and capillary electrophoretic investigation of the enzymatic degradation of heparin-like glycosaminoglycans","volume":"95","author":"Rhomberg","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib693","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1073\/pnas.95.21.12232","article-title":"Mass spectrometric evidence for the enzymatic mechanism of the depolymerization of heparin-like glycosaminoglycans by heparinase II","volume":"95","author":"Rhomberg","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib694","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijcard.2014.09.105","article-title":"Optimal anticoagulation duration of unfractionated and low molecular weight heparin in non-ST elevation acute coronary syndrome: a systematic review of the literature","volume":"177","author":"Riaz","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1124\/pr.115.011247_bib1020","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1021\/bi00188a029","article-title":"Anti-HIV-1 activity of chemically modified heparins: correlation between binding to the V3 loop of Gp120 and inhibition of cellular HIV-1 infection in vitro","volume":"33","author":"Rider","year":"1994","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20100305","article-title":"Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists","volume":"429","author":"Rider","year":"2010","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib696","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1016\/j.biomaterials.2014.04.027","article-title":"Controlled release and gradient formation of human glial-cell derived neurotrophic factor from heparinated poly(ethylene glycol) microsphere-based scaffolds","volume":"35","author":"Roam","year":"2014","journal-title":"Biomaterials"},{"key":"10.1124\/pr.115.011247_bib697","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/332376a0","article-title":"Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis","volume":"332","author":"Roberts","year":"1988","journal-title":"Nature"},{"key":"10.1124\/pr.115.011247_bib698","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010837.pub2","article-title":"Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE","volume":"3","author":"Robertson","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pr.115.011247_bib965","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1074\/jbc.M510760200","article-title":"VEGF165-binding sites within heparan sulfate encompass two highly sulphated domains and can be liberated by K5 Lyase","volume":"281","author":"Robinson","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib699","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1471-0528.2002.01525.x","article-title":"Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series","volume":"109","author":"Rodie","year":"2002","journal-title":"BJOG"},{"key":"10.1124\/pr.115.011247_bib700","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0741-5214(92)90456-I","article-title":"High-dose heparin suppresses platelet alpha granule secretion","volume":"15","author":"Rohrer","year":"1992","journal-title":"J Vasc Surg"},{"key":"10.1124\/pr.115.011247_bib701","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2014.06.033","article-title":"Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach","volume":"36","author":"Rollins","year":"2014","journal-title":"Clin Ther"},{"key":"10.1124\/pr.115.011247_bib702","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000368403","article-title":"Granzyme H is a novel protease expressed by human mast cells","volume":"165","author":"R\u00f6nnberg","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1124\/pr.115.011247_bib703","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1369\/0022155412458927","article-title":"Mast cell proteoglycans","volume":"60","author":"R\u00f6nnberg","year":"2012","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/pr.115.011247_bib704","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-61779-498-8_14","article-title":"Serglycin: the master of the mast cell","volume":"836","author":"R\u00f6nnberg","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pr.115.011247_bib705","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1073\/pnas.76.3.1218","article-title":"Correlation between structure and function of heparin","volume":"76","author":"Rosenberg","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib706","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.4049\/jimmunol.0902016","article-title":"Functional characterization of the recombinant human C1 inhibitor serpin domain: insights into heparin binding","volume":"184","author":"Rossi","year":"2010","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011247_bib707","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/glycob\/cwr053","article-title":"Bioactivity screening of partially desulfated low-molecular-weight heparins: a structure\/activity relationship study","volume":"21","author":"Roy","year":"2011","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib708","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.sbi.2010.08.004","article-title":"The conformation and structure of GAGs: recent progress and perspectives","volume":"20","author":"Rudd","year":"2010","journal-title":"Curr Opin Struct Biol"},{"key":"10.1124\/pr.115.011247_bib709","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1021\/ac301428d","article-title":"How to find a needle (or anything else) in a haystack: two-dimensional correlation spectroscopy-filtering with iterative random sampling applied to pharmaceutical heparin","volume":"84","author":"Rudd","year":"2012","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib710","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1039\/c0ob00246a","article-title":"Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationships","volume":"8","author":"Rudd","year":"2010","journal-title":"Org Biomol Chem"},{"key":"10.1124\/pr.115.011247_bib711","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0008-6215(94)80084-7","article-title":"NMR assignment and conformational analysis of the antigenic capsular polysaccharide from Streptococcus pneumoniae type 9N in aqueous solution","volume":"265","author":"Rutherford","year":"1994","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib712","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1016\/j.biomaterials.2010.02.026","article-title":"The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model","volume":"31","author":"Ruvinov","year":"2010","journal-title":"Biomaterials"},{"key":"10.1124\/pr.115.011247_bib713","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/TA.0b013e31825a0519","article-title":"Insertion of central venous catheters induces a hypercoagulable state","volume":"73","author":"Ryan","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1124\/pr.115.011247_bib714","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1074\/jbc.M008110200","article-title":"Characterization of the stromal cell-derived factor-1alpha-heparin complex","volume":"276","author":"Sadir","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib715","doi-asserted-by":"crossref","first-page":"9384","DOI":"10.1021\/ja4000867","article-title":"Insights into the mechanism by which interferon-\u03b3 basic amino acid clusters mediate protein binding to heparan sulfate","volume":"135","author":"Saesen","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.115.011247_bib716","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1074\/jbc.272.14.9457","article-title":"Heparin binding and oligomerization of hepatocyte growth factor\/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling","volume":"272","author":"Sakata","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib717","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/gut.47.1.88","article-title":"Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism","volume":"47","author":"Salas","year":"2000","journal-title":"Gut"},{"key":"10.1124\/pr.115.011247_bib718","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1160\/TH03-02-0088","article-title":"Inhibition of thrombosis in melanoma allografts in mice by endogenous mast cell heparin","volume":"90","author":"Samoszuk","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib719","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2407-5-121","article-title":"Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts","volume":"5","author":"Samoszuk","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1124\/pr.115.011247_bib720","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.carres.2013.09.005","article-title":"Importance of IdoA and IdoA(2S) ring conformations in computational studies of glycosaminoglycan-protein interactions","volume":"381","author":"Samsonov","year":"2013","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib721","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10822-011-9433-1","article-title":"Docking glycosaminoglycans to proteins: analysis of solvent inclusion","volume":"25","author":"Samsonov","year":"2011","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/pr.115.011247_bib722","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1042\/bj2430175","article-title":"Conformational equilibria of alpha-L-iduronate residues in disaccharides derived from heparin","volume":"243","author":"Sanderson","year":"1987","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib723","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0049-3848(88)90340-4","article-title":"Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)","volume":"50","author":"Sandset","year":"1988","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib724","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.drudis.2014.07.004","article-title":"Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs","volume":"19","author":"Santos","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1124\/pr.115.011247_bib725","doi-asserted-by":"crossref","DOI":"10.1016\/S0272-6386(03)00211-7","article-title":"Diffuse alopecia in a hemodialysis patient caused by a low-molecular-weight heparin, tinzaparin","volume":"41","author":"Sarris","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/pr.115.011247_bib726","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1476-5381.1993.tb13778.x","article-title":"Effect of heparin and a low-molecular weight heparinoid on PAF-induced airway responses in neonatally immunized rabbits","volume":"110","author":"Sasaki","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib727","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1160\/TH09-02-0083","article-title":"From crisis to opportunity: a perspective on the heparin crisis","volume":"102","author":"Sasisekharan","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib728","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/glycob\/cwr101","article-title":"Is N-acetyl-D-glucosamine a rigid 4C1 chair?","volume":"21","author":"Sattelle","year":"2011","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib729","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2004-05-2010","article-title":"Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin","volume":"105","author":"Savi","year":"2005","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib730","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1538-7836.2010.03795.x","article-title":"Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopenia","volume":"8","author":"Schindewolf","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib731","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4065\/mcp.2010.0346","article-title":"Low allergenic potential with fondaparinux: results of a prospective investigation","volume":"85","author":"Schindewolf","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1124\/pr.115.011247_bib732","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1503\/cmaj.081729","article-title":"Incidence and causes of heparin-induced skin lesions","volume":"181","author":"Schindewolf","year":"2009","journal-title":"CMAJ"},{"key":"10.1124\/pr.115.011247_bib733","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.thromres.2014.03.029","article-title":"Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study","volume":"134","author":"Schindewolf","year":"2014","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib734","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1097-2765(00)00073-3","article-title":"Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization","volume":"6","author":"Schlessinger","year":"2000","journal-title":"Mol Cell"},{"key":"10.1124\/pr.115.011247_bib735","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.carres.2012.02.025","article-title":"The influence of glycosaminoglycans on IL-8-mediated functions of neutrophils","volume":"356","author":"Schlorke","year":"2012","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib736","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2174\/1389201015666140915151649","article-title":"Current developments for the oral delivery of heparin","volume":"15","author":"Schl\u00fcter","year":"2014","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1124\/pr.115.011247_bib737","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2843","article-title":"The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis","volume":"18","author":"Schmidt","year":"2012","journal-title":"Nat Med"},{"key":"10.1124\/pr.115.011247_bib738","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00216-010-4220-8","article-title":"Protamine neutralisation of low molecular weight heparins and their oligosaccharide components","volume":"399","author":"Schroeder","year":"2011","journal-title":"Anal Bioanal Chem"},{"issue":"Suppl","key":"10.1124\/pr.115.011247_bib739","doi-asserted-by":"crossref","first-page":"257S","DOI":"10.1378\/chest.08-0674","article-title":"Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Schulman","year":"2008","journal-title":"Chest"},{"key":"10.1124\/pr.115.011247_bib740","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.1002\/chem.201204519","article-title":"Synthesis of a targeted library of heparan sulfate hexa- to dodecasaccharides as inhibitors of \u03b2-secretase: potential therapeutics for Alzheimer\u2019s disease","volume":"19","author":"Schw\u00f6rer","year":"2013","journal-title":"Chemistry"},{"key":"10.1124\/pr.115.011247_bib741","first-page":"132","article-title":"Treatment with modified heparins inhibits experimental metastasis formation and leads, in some animals, to long-term survival","volume":"16","author":"Sciumbata","year":"1996","journal-title":"Invasion Metastasis"},{"key":"10.1124\/pr.115.011247_bib742","doi-asserted-by":"crossref","first-page":"31949","DOI":"10.1074\/jbc.M505314200","article-title":"Heparin-binding sites in granulocyte-macrophage colony-stimulating factor. Localization and regulation by histidine ionization","volume":"280","author":"Sebollela","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib743","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nature05819","article-title":"Synthesis and medical applications of oligosaccharides","volume":"446","author":"Seeberger","year":"2007","journal-title":"Nature"},{"key":"10.1124\/pr.115.011247_bib744","first-page":"269","article-title":"The effect of heparin and related proteoglycans on allergen and PAF-induced eosinophil infiltration","volume":"7","author":"Seeds","year":"1993","journal-title":"J Lipid Mediat"},{"key":"10.1124\/pr.115.011247_bib745","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/pulp.1995.1012","article-title":"The effect of inhaled heparin and related glycosaminoglycans on allergen-induced eosinophil infiltration in guinea-pigs","volume":"8","author":"Seeds","year":"1995","journal-title":"Pulm Pharmacol"},{"key":"10.1124\/pr.115.011247_bib746","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/pupt.2000.0277","article-title":"Heparin inhibits allergen-induced eosinophil infiltration into guinea-pig lung via a mechanism unrelated to its anticoagulant activity","volume":"14","author":"Seeds","year":"2001","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1124\/pr.115.011247_bib747","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-60761-533-0_2","article-title":"New protocol for lentiviral vector mass production","volume":"614","author":"Segura","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pr.115.011247_bib748","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jss.2009.01.028","article-title":"Topical heparin: a promising agent for the prevention of tracheal stenosis in airway surgery","volume":"157","author":"Sen","year":"2009","journal-title":"J Surg Res"},{"key":"10.1124\/pr.115.011247_bib749","doi-asserted-by":"crossref","first-page":"10486","DOI":"10.1021\/bi1011749","article-title":"Interaction of human \u03b2-defensin 2 (HBD2) with glycosaminoglycans","volume":"49","author":"Seo","year":"2010","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib750","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1021\/ja310915m","article-title":"Differentiation of CC vs CXC chemokine dimers with GAG octasaccharide binding partners: an ion mobility mass spectrometry approach","volume":"135","author":"Seo","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.115.011247_bib751","doi-asserted-by":"crossref","first-page":"17713","DOI":"10.1074\/jbc.M109.082552","article-title":"Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans","volume":"285","author":"Severin","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib752","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cis.2010.03.001","article-title":"Glycosaminoglycans as polyelectrolytes","volume":"158","author":"Seyrek","year":"2010","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1124\/pr.115.011247_bib753","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jvs.2007.11.030","article-title":"Endogenous heparin activity is decreased in peripheral arterial occlusive disease","volume":"47","author":"Shankar","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1124\/pr.115.011247_bib754","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1378\/chest.08-2830","article-title":"Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management","volume":"135","author":"Shantsila","year":"2009","journal-title":"Chest"},{"key":"10.1124\/pr.115.011247_bib755","doi-asserted-by":"crossref","first-page":"31689","DOI":"10.1074\/jbc.M604502200","article-title":"Crystallographic analysis of calcium-dependent heparin binding to annexin A2","volume":"281","author":"Shao","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib756","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.thromres.2015.01.009","article-title":"New oral anticoagulants in the treatment of heparin-induced thrombocytopenia","volume":"135","author":"Sharifi","year":"2015","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib757","first-page":"86","article-title":"Structural basis of heparin binding to camel peptidoglycan recognition protein-S","volume":"3","author":"Sharma","year":"2012","journal-title":"Int J Biochem Mol Biol"},{"key":"10.1124\/pr.115.011247_bib758","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1007\/s00216-013-6996-9","article-title":"Ion exchange chromatographic separation and isolation of oligosaccharides of intact low-molecular-weight heparin for the determination of their anticoagulant and anti-inflammatory properties","volume":"405","author":"Shastri","year":"2013","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pr.115.011247_bib759","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1517\/13543784.2014.866092","article-title":"Non-anticoagulant derivatives of heparin for the management of asthma: distant dream or close reality?","volume":"23","author":"Shastri","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/pr.115.011247_bib760","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1182\/blood.V86.4.1368.bloodjournal8641368","article-title":"The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria","volume":"86","author":"Shaughnessy","year":"1995","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib761","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.str.2004.08.014","article-title":"The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors","volume":"12","author":"Shaw","year":"2004","journal-title":"Structure"},{"key":"10.1124\/pr.115.011247_bib762","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2036.2007.03418.x","article-title":"Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis","volume":"26","author":"Shen","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/pr.115.011247_bib763","doi-asserted-by":"crossref","first-page":"19768","DOI":"10.1074\/jbc.M111.224311","article-title":"The dominating role of N-deacetylase\/N-sulfotransferase 1 in forming domain structures in heparan sulfate","volume":"286","author":"Sheng","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib764","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ygyno.2007.08.057","article-title":"Evaluation of candidate methylation markers to detect cervical neoplasia","volume":"107","author":"Shivapurkar","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1124\/pr.115.011247_bib765","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-3-642-23056-1_8","article-title":"Heparin and heparan sulfate: analyzing structure and microheterogeneity","volume":"207","author":"Shriver","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pr.115.011247_bib766","doi-asserted-by":"crossref","first-page":"10359","DOI":"10.1073\/pnas.97.19.10359","article-title":"Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site","volume":"97","author":"Shriver","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib767","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nchem.1701","article-title":"Heparin sensing: blue-chip binding","volume":"5","author":"Shriver","year":"2013","journal-title":"Nat Chem"},{"key":"10.1124\/pr.115.011247_bib768","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4939-1714-3_15","article-title":"Capillary electrophoretic analysis of isolated sulfated polysaccharides to characterize pharmaceutical products","volume":"1229","author":"Shriver","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pr.115.011247_bib769","doi-asserted-by":"crossref","first-page":"10365","DOI":"10.1073\/pnas.97.19.10365","article-title":"Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin","volume":"97","author":"Shriver","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib770","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/03639040701657552","article-title":"The spray drying of unfractionated heparin: optimization of the operating parameters","volume":"34","author":"Shur","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1124\/pr.115.011247_bib967","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-3-642-23056-1_13","article-title":"Glycosaminoglycan and chemokine interactions","volume":"207","author":"Shute","year":"2012","journal-title":"Handbook Exp Pharmacol"},{"key":"10.1124\/pr.115.011247_bib771","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000237604","article-title":"Urinary glycosaminoglycan levels are increased in acute severe asthma--a role for eosinophil-derived gelatinase B?","volume":"113","author":"Shute","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1124\/pr.115.011247_bib772","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1877-1173(10)93008-1","article-title":"Anticoagulant heparan sulfate to not clot--or not?","volume":"93","author":"Shworak","year":"2010","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1124\/pr.115.011247_bib773","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1074\/jbc.274.8.5170","article-title":"Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cDNAs and identification of distinct genomic loci","volume":"274","author":"Shworak","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib774","doi-asserted-by":"crossref","first-page":"12560","DOI":"10.1021\/bi060964o","article-title":"Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy","volume":"45","author":"Sibille","year":"2006","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib775","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1051\/ject\/200941073","article-title":"Trends and emerging technologies in extracorporeal life support: results of the 2006 ECLS survey","volume":"41","author":"Sievert","year":"2009","journal-title":"J Extra Corpor Technol"},{"key":"10.1124\/pr.115.011247_bib776","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1538-7836.2011.04458.x","article-title":"No accumulation of the peak anti-factor Xa activity of tinzaparin in elderly patients with moderate-to-severe renal impairment: the IRIS substudy","volume":"9","author":"Siguret","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib777","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e553","article-title":"Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis","volume":"344","author":"Silvain","year":"2012","journal-title":"BMJ"},{"key":"10.1124\/pr.115.011247_bib778","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-2007-1001910","article-title":"Effects of heparin and its desulfated derivatives on leukocyte-endothelial adhesion","volume":"20","author":"Silvestro","year":"1994","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pr.115.011247_bib779","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12028-010-9435-1","article-title":"Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage","volume":"13","author":"Simard","year":"2010","journal-title":"Neurocrit Care"},{"key":"10.1124\/pr.115.011247_bib780","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1055\/s-2007-982085","article-title":"Affinity and kinetics of different heparins binding to P- and L-selectin","volume":"33","author":"Simonis","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pr.115.011247_bib781","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1021\/bi602347g","article-title":"Kinetic analysis of heparin and glucan sulfates binding to P-selectin and its impact on the general understanding of selectin inhibition","volume":"46","author":"Simonis","year":"2007","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib782","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/bj1910103","article-title":"Structural studies on heparan sulphate from human lung fibroblasts. Characterization of oligosaccharides obtained by selective periodate oxidation of D-glucuronic acid residues followed by scission in alkali","volume":"191","author":"Sj\u00f6berg","year":"1980","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib783","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/nprot.2010.145","article-title":"Disaccharide compositional analysis of heparan sulfate and heparin polysaccharides using UV or high-sensitivity fluorescence (BODIPY) detection","volume":"5","author":"Skidmore","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1124\/pr.115.011247_bib784","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/03008200802148595","article-title":"The activities of heparan sulfate and its analogue heparin are dictated by biosynthesis, sequence, and conformation","volume":"49","author":"Skidmore","year":"2008","journal-title":"Connect Tissue Res"},{"key":"10.1124\/pr.115.011247_bib785","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1016\/S0021-9258(19)67603-9","article-title":"GMP-140 binding to neutrophils is inhibited by sulfated glycans","volume":"266","author":"Skinner","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib786","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.1016\/j.actbio.2013.02.043","article-title":"Heparin crosslinked chitosan microspheres for the delivery of neural stem cells and growth factors for central nervous system repair","volume":"9","author":"Skop","year":"2013","journal-title":"Acta Biomater"},{"key":"10.1124\/pr.115.011247_bib787","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1084\/jem.171.6.2025","article-title":"Tumor necrosis factor alpha\/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium","volume":"171","author":"Slungaard","year":"1990","journal-title":"J Exp Med"},{"key":"10.1124\/pr.115.011247_bib788","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/sj.bjp.0704321","article-title":"The effects of heparin on the adhesion of human peripheral blood mononuclear cells to human stimulated umbilical vein endothelial cells","volume":"134","author":"Smailbegovic","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib789","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/bj20021666","article-title":"Substrate specificities of mouse heparan sulphate glucosaminyl 6-O-sulphotransferases","volume":"372","author":"Smeds","year":"2003","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib790","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1055\/s-0037-1614885","article-title":"The effects of unfractionated heparin on survival in patients with malignancy--a systematic review","volume":"82","author":"Smorenburg","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib791","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(24)01481-9","article-title":"The complex effects of heparins on cancer progression and metastasis in experimental studies","volume":"53","author":"Smorenburg","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.115.011247_bib792","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1067\/mva.2001.112696","article-title":"Heparin modulates integrin function in human platelets","volume":"33","author":"Sobel","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1124\/pr.115.011247_bib793","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00216-011-5362-z","article-title":"Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns","volume":"401","author":"Sommers","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pr.115.011247_bib794","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1525-139X.2006.00177.x","article-title":"The safety of heparins in end-stage renal disease","volume":"19","author":"Sonawane","year":"2006","journal-title":"Semin Dial"},{"key":"10.1124\/pr.115.011247_bib1023","doi-asserted-by":"crossref","first-page":"15487","DOI":"10.1074\/jbc.273.25.15487","article-title":"Defining the interleukin-8-binding domain of heparin sulfate","volume":"273","author":"Spillmann","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib966","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1126\/science.1256478","article-title":"Neutrophils scan for activated platelets to initiate inflammation","volume":"346","author":"Sreevarkumar","year":"2014","journal-title":"Science"},{"key":"10.1124\/pr.115.011247_bib795","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00216-010-4277-4","article-title":"The development of an FIA-CD strategy for screening sulfated polysaccharides using antimalarial drugs and related species as probes","volume":"399","author":"Stanley","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pr.115.011247_bib796","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/1078-0432.CCR-05-1131","article-title":"Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity","volume":"11","author":"Stevenson","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"Suppl 2","key":"10.1124\/pr.115.011247_bib797","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/S0049-3848(07)70138-X","article-title":"Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects","volume":"120","author":"Stevenson","year":"2007","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib798","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0038-1661167","article-title":"Haemostasis in normal pregnancy","volume":"52","author":"Stirling","year":"1984","journal-title":"Thromb Haemost"},{"issue":"2010","key":"10.1124\/pr.115.011247_bib799","first-page":"20","article-title":"heparanase of murine effector lymphocytes and neutrophils is not required for their daipedesis into sites of inflammation","volume":"29","author":"Stoler-Barak","year":"2015","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.011247_bib800","first-page":"1-1-6","article-title":"Optical conformation of heparin and heparin complexes with cationic dyes, amines and protein models","volume":"36","author":"Stone","year":"1977","journal-title":"Fed Proc"},{"issue":"5","key":"10.1124\/pr.115.011247_bib1022","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1182\/blood.V100.5.1543.h81702001543_1543_1550","article-title":"Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha","volume":"100","author":"Stringer","year":"2002","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib801","doi-asserted-by":"crossref","first-page":"20508","DOI":"10.1074\/jbc.272.33.20508","article-title":"Specific binding of the chemokine platelet factor 4 to heparan sulfate","volume":"272","author":"Stringer","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib802","doi-asserted-by":"crossref","first-page":"10436","DOI":"10.1021\/bi010847n","article-title":"Structures of heparin-derived disaccharide bound to cobra cardiotoxins: context-dependent conformational change of heparin upon binding to the rigid core of the three-fingered toxin","volume":"40","author":"Sue","year":"2001","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib803","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0041-0101(86)90149-2","article-title":"Actions of cardiotoxins from the southern Chinese cobra (Naja naja atra) on rat cardiac tissue","volume":"24","author":"Sun","year":"1986","journal-title":"Toxicon"},{"key":"10.1124\/pr.115.011247_bib804","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1021\/bi802138m","article-title":"Heparin enhances the inhibition of factor Xa by protein C inhibitor in the presence but not in the absence of Ca2+","volume":"48","author":"Sun","year":"2009","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib805","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1074\/jbc.M411395200","article-title":"Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1","volume":"280","author":"Suto","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib806","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1182\/blood-2007-08-105098","article-title":"Determinants of PF4\/heparin immunogenicity","volume":"110","author":"Suvarna","year":"2007","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib807","doi-asserted-by":"crossref","first-page":"14152","DOI":"10.1021\/bi051112b","article-title":"Eosinophil-granule major basic protein, a C-type lectin, binds heparin","volume":"44","author":"Swaminathan","year":"2005","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib808","doi-asserted-by":"crossref","first-page":"26197","DOI":"10.1074\/jbc.M100848200","article-title":"Crystal structure of the eosinophil major basic protein at 1.8 A. An atypical lectin with a paradigm shift in specificity","volume":"276","author":"Swaminathan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib809","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0008-8749(83)90137-5","article-title":"Inhibition of delayed-type hypersensitivity by heparin depleted of anticoagulant activity","volume":"82","author":"Sy","year":"1983","journal-title":"Cell Immunol"},{"key":"10.1124\/pr.115.011247_bib810","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2222.1991.tb01680.x","article-title":"Delayed generation of thrombin in clotting blood of atopic patients with hayfever and asthma","volume":"21","author":"Szczeklik","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1124\/pr.115.011247_bib811","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1039\/b917287d","article-title":"A fluorescent probe for the quantification of heparin in clinical samples with minimal matrix interference","volume":"46","author":"Szelke","year":"2010","journal-title":"Chem Commun (Camb)"},{"key":"10.1124\/pr.115.011247_bib812","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.2015.517","article-title":"Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction","volume":"313","author":"Szummer","year":"2015","journal-title":"JAMA"},{"key":"10.1124\/pr.115.011247_bib813","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1248\/cpb.38.2503","article-title":"Quality check of heparin injections by 1H-nuclear magnetic resonance spectroscopy","volume":"38","author":"Tachibana","year":"1990","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1124\/pr.115.011247_bib814","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.bjp.0706344","article-title":"A comparison of the effects of unfractionated heparin, dalteparin and danaparoid on vascular endothelial growth factor-induced tumour angiogenesis and heparanase activity","volume":"146","author":"Takahashi","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib815","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1016\/j.biomaterials.2008.08.024","article-title":"Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants","volume":"29","author":"Tami","year":"2008","journal-title":"Biomaterials"},{"key":"10.1124\/pr.115.011247_bib816","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1369\/0022155412465090","article-title":"Heparan sulfate biosynthesis enzymes in embryonic stem cell biology","volume":"60","author":"Tamm","year":"2012","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/pr.115.011247_bib817","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1074\/jbc.M705203200","article-title":"Heparin-induced cis- and trans-dimerization modes of the thrombospondin-1 N-terminal domain","volume":"283","author":"Tan","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib818","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.str.2005.09.017","article-title":"The structures of the thrombospondin-1 N-terminal domain and its complex with a synthetic pentameric heparin","volume":"14","author":"Tan","year":"2006","journal-title":"Structure"},{"key":"10.1124\/pr.115.011247_bib819","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood.V77.7.1565.1565","article-title":"Inhibition of leukocyte rolling in venules by protamine and sulfated polysaccharides","volume":"77","author":"Tangelder","year":"1991","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib820","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.4049\/jimmunol.0903274","article-title":"Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs","volume":"184","author":"Tanino","year":"2010","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011247_bib821","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1586\/17434440.2.4.473","article-title":"Bioactive technologies for hemocompatibility","volume":"2","author":"Tanzi","year":"2005","journal-title":"Expert Rev Med Devices"},{"key":"10.1124\/pr.115.011247_bib822","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1538-7836.2009.03514.x","article-title":"Thrombin generation and heparin-induced thrombocytopenia","volume":"7","author":"Tardy-Poncet","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib823","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fj.05-4682rev","article-title":"Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation","volume":"20","author":"Taylor","year":"2006","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.011247_bib824","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/j.1476-5381.1993.tb13991.x","article-title":"Suppression by intradermal administration of heparin of eosinophil accumulation but not oedema formation in inflammatory reactions in guinea-pig skin","volume":"110","author":"Teixeira","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib825","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/jlb.59.3.389","article-title":"Adhesion mechanisms involved in C5a-induced eosinophil homotypic aggregation","volume":"59","author":"Teixeira","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1124\/pr.115.011247_bib826","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF01808557","article-title":"Preventive effect of intracisternal heparin for proliferative angiopathy after experimental subarachnoid haemorrhage in rats","volume":"127","author":"Tekk\u00f6k","year":"1994","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1124\/pr.115.011247_bib827","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0141-8130(88)90038-4","article-title":"General occurrence of isosbestic points in the metachromatic dye complexes of sulphated glycosaminoglycans","volume":"10","author":"Templeton","year":"1988","journal-title":"Int J Biol Macromol"},{"key":"10.1124\/pr.115.011247_bib828","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006681.pub2","article-title":"Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization","volume":"4","author":"Testroote","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1124\/pr.115.011247_bib829","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.matbio.2013.12.001","article-title":"Heparan sulfate 3-O-sulfation: a rare modification in search of a function","volume":"35","author":"Thacker","year":"2014","journal-title":"Matrix Biol"},{"key":"10.1124\/pr.115.011247_bib830","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2141.1975.tb00853.x","article-title":"A simple two-step isolation procedure for human and bovine antithrombin II\/III (heparin cofactor): a comparison of two methods","volume":"31","author":"Thaler","year":"1975","journal-title":"Br J Haematol"},{"key":"10.1124\/pr.115.011247_bib831","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/01.CIR.85.4.1380","article-title":"Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study","volume":"85","author":"Th\u00e9ry","year":"1992","journal-title":"Circulation"},{"key":"10.1124\/pr.115.011247_bib832","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2013.06.013","article-title":"Polysaccharide-modified scaffolds for controlled lentivirus delivery in vitro and after spinal cord injury","volume":"170","author":"Thomas","year":"2013","journal-title":"J Control Release"},{"key":"10.1124\/pr.115.011247_bib833","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0008-6215(00)81050-2","article-title":"Further characterization of the antithrombin-binding sequence in heparin","volume":"100","author":"Thunberg","year":"1982","journal-title":"Carbohydr Res"},{"key":"10.1124\/pr.115.011247_bib834","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1046\/j.1432-1033.2003.03870.x","article-title":"Interaction of the C1 complex of complement with sulfated polysaccharide and DNA probed by single molecule fluorescence microscopy","volume":"270","author":"Tissot","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1124\/pr.115.011247_bib835","doi-asserted-by":"crossref","first-page":"9941","DOI":"10.1021\/bi700995v","article-title":"Structures of heparin-derived tetrasaccharide bound to cobra cardiotoxins: heparin binding at a single protein site with diverse side chain interactions","volume":"46","author":"Tjong","year":"2007","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib836","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-4615-5391-5_4","article-title":"Heparin cofactor II","volume":"425","author":"Tollefsen","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1124\/pr.115.011247_bib837","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1877-1173(10)93015-9","article-title":"Vascular dermatan sulfate and heparin cofactor II","volume":"93","author":"Tollefsen","year":"2010","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1124\/pr.115.011247_bib838","first-page":"53","article-title":"Management of acute smoke inhalation injury","volume":"12","author":"Toon","year":"2010","journal-title":"Crit Care Resusc"},{"key":"10.1124\/pr.115.011247_bib839","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jmr.1027","article-title":"Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site","volume":"24","author":"Torrent","year":"2011","journal-title":"J Mol Recognit"},{"key":"10.1124\/pr.115.011247_bib840","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbadis.2005.02.008","article-title":"Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II","volume":"1740","author":"Tovar","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.115.011247_bib841","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1756-0500-6-230","article-title":"Bovine and porcine heparins: different drugs with similar effects on human haemodialysis","volume":"6","author":"Tovar","year":"2013","journal-title":"BMC Res Notes"},{"key":"10.1124\/pr.115.011247_bib842","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jpba.2008.12.013","article-title":"Analysis of heparin sodium by SAX\/HPLC for contaminants and impurities","volume":"49","author":"Trehy","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pr.115.011247_bib843","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0962-8924(00)01897-3","article-title":"Heparan sulfate: decoding a dynamic multifunctional cell regulator","volume":"11","author":"Turnbull","year":"2001","journal-title":"Trends Cell Biol"},{"key":"10.1124\/pr.115.011247_bib1025","doi-asserted-by":"crossref","first-page":"10337","DOI":"10.1016\/S0021-9258(19)50023-0","article-title":"Identification of the basic fibroblast growth factor binding sequence in fibroblast heparin sulphate","volume":"267","author":"Turnbull","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib844","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1073\/pnas.96.6.2698","article-title":"A strategy for rapid sequencing of heparan sulfate and heparin saccharides","volume":"96","author":"Turnbull","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"10.1124\/pr.115.011247_bib845","first-page":"107","article-title":"Mucopolysaccharidosis type II, Hunter\u2019s syndrome","volume":"12","author":"Tylki-Szyma\u0144ska","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1124\/pr.115.011247_bib846","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1054-3589(08)60471-8","article-title":"Heparin in inflammation: potential therapeutic applications beyond anticoagulation","volume":"46","author":"Tyrrell","year":"1999","journal-title":"Adv Pharmacol"},{"key":"10.1124\/pr.115.011247_bib847","first-page":"7855","article-title":"Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells","volume":"61","author":"Uno","year":"2001","journal-title":"Cancer Res"},{"key":"10.1124\/pr.115.011247_bib848","series-title":"United States Pharmacopeia and National Formulary (USP 37-NF-32)","first-page":"3748","article-title":"USP 37 official monographs: heparin sodium","year":"2014"},{"key":"10.1124\/pr.115.011247_bib849","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.2741\/4066","article-title":"Structural biology of factor VIIa\/tissue factor initiated coagulation","volume":"17","author":"Vadivel","year":"2012","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1124\/pr.115.011247_bib850","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1039\/c2nr32821f","article-title":"Demonstration of specific binding of heparin to Plasmodium falciparum-infected vs. non-infected red blood cells by single-molecule force spectroscopy","volume":"5","author":"Valle-Delgado","year":"2013","journal-title":"Nanoscale"},{"key":"10.1124\/pr.115.011247_bib851","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/07328308508070182","article-title":"Synthesis of a pentasaccharide corresponding to the antithrombin III binding fragment of heparin","volume":"4","author":"van Boeckel","year":"1985","journal-title":"J Carbohydr Chem"},{"key":"10.1124\/pr.115.011247_bib852","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/anie.199316713","article-title":"The unique antithrombin III binding domain of heparin: a lead to new synthetic antithrombotics","volume":"32","author":"van Boeckel","year":"1993","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1124\/pr.115.011247_bib968","first-page":"202","article-title":"Determinations of the molecular mass of low molecular mass (LMM) heparin","volume":"3","author":"Van Dedem","year":"1991","journal-title":"Pharmaeuropa"},{"key":"10.1124\/pr.115.011247_bib853","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jb\/mvq060","article-title":"Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor","volume":"148","author":"Van Walderveen","year":"2010","journal-title":"J Biochem"},{"key":"10.1124\/pr.115.011247_bib854","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1067\/mai.2001.118785","article-title":"Intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis","volume":"108","author":"Vancheri","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"33","key":"10.1124\/pr.115.011247_bib1027","doi-asserted-by":"crossref","first-page":"24416","DOI":"10.1074\/jbc.M701835200","article-title":"The heparin\/heparan sulfate sequence that interacts with cyclophilin B contains a 3-O-sulfated N-unsubstituted glucosamine residue","volume":"282","author":"Vanpouille","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib1028","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/BJ20040757","article-title":"NMR Characterization of the interaction between the C-Terminal Domain of interferon-gamma and heparin-derived oligosaccharides","volume":"384","author":"Vanhaverbeke","year":"2004","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib855","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.4049\/jimmunol.1302159","article-title":"Chemokine cooperativity is caused by competitive glycosaminoglycan binding","volume":"192","author":"Verkaar","year":"2014","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011247_bib856","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00016.2011","article-title":"New fundamentals in hemostasis","volume":"93","author":"Versteeg","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1124\/pr.115.011247_bib857","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074035","article-title":"Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III","volume":"8","author":"Vervaeke","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011247_bib858","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1074\/jbc.M807994200","article-title":"Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation","volume":"284","author":"Veverka","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib859","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1007\/s11095-013-1043-2","article-title":"Oral delivery of low molecular weight heparin by polyaminomethacrylate coacervates","volume":"30","author":"Viehof","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/pr.115.011247_bib860","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1096\/fj.13-246777","article-title":"Heparin binding confers prion stability and impairs its aggregation","volume":"28","author":"Vieira","year":"2014","journal-title":"FASEB J"},{"key":"10.1124\/pr.115.011247_bib861","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/ja106725p","article-title":"Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species","volume":"133","author":"Vieira","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1124\/pr.115.011247_bib862","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1160\/TH06-11-0671","article-title":"Heparin induces mobilization of osteoprotegerin into the circulation","volume":"98","author":"Vik","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib863","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/1076029609338710","article-title":"Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin","volume":"15","author":"Viskov","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1124\/pr.115.011247_bib864","doi-asserted-by":"crossref","first-page":"25895","DOI":"10.1074\/jbc.M113.485268","article-title":"Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties","volume":"288","author":"Viskov","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib865","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1538-7836.2009.03447.x","article-title":"Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra-low-molecular-weight heparin, AVE5026","volume":"7","author":"Viskov","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib1024","doi-asserted-by":"crossref","first-page":"14779","DOI":"10.1021\/bi026459i","article-title":"A kinetics and modelling study of RANTES (9-68) Binding to heparin reveals a mechanism of cooperative oligomerization","volume":"41","author":"Vives","year":"2002","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib866","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1074\/jbc.M310691200","article-title":"Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist Noggin","volume":"279","author":"Viviano","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib867","first-page":"112","article-title":"Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation","volume":"12","author":"Vlodavsky","year":"1992","journal-title":"Invasion Metastasis"},{"key":"10.1124\/pr.115.011247_bib868","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10019","article-title":"Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: basic aspects and clinical applications","volume":"2","author":"Vlodavsky","year":"2011","journal-title":"Rambam Maimonides Med J"},{"key":"10.1124\/pr.115.011247_bib869","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/10518","article-title":"Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis","volume":"5","author":"Vlodavsky","year":"1999","journal-title":"Nat Med"},{"key":"10.1124\/pr.115.011247_bib870","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0020100","article-title":"Release of sequestered malaria parasites upon injection of a glycosaminoglycan","volume":"2","author":"Vogt","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1124\/pr.115.011247_bib871","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0021-9673(93)80476-O","article-title":"Glycosaminoglycans and proteins: different behaviours in high-performance size-exclusion chromatography","volume":"630","author":"Volpi","year":"1993","journal-title":"J Chromatogr A"},{"key":"10.1124\/pr.115.011247_bib872","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nprot.2010.48","article-title":"High-performance liquid chromatography-mass spectrometry for mapping and sequencing glycosaminoglycan-derived oligosaccharides","volume":"5","author":"Volpi","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1124\/pr.115.011247_bib873","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1002\/elps.200290021","article-title":"Detection of submicrogram quantities of glycosaminoglycans on agarose gels by sequential staining with toluidine blue and Stains-All","volume":"23","author":"Volpi","year":"2002","journal-title":"Electrophoresis"},{"key":"10.1124\/pr.115.011247_bib874","doi-asserted-by":"crossref","first-page":"9661","DOI":"10.1074\/jbc.272.15.9661","article-title":"Analysis of binding of cobra cardiotoxins to heparin reveals a new beta-sheet heparin-binding structural motif","volume":"272","author":"Vyas","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib875","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2133.2004.05853.x","article-title":"Assessment of the biological performance of the needle-free injector INJEX using the isolated porcine forelimb","volume":"150","author":"Wagner","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1124\/pr.115.011247_bib876","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/bj2570191","article-title":"Effect of heparin on the glia-derived-nexin-thrombin interaction","volume":"257","author":"Wallace","year":"1989","journal-title":"Biochem J"},{"key":"10.1124\/pr.115.011247_bib877","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/cs0810341","article-title":"Heparin and heparan sulphate are inhibitors of human leucocyte elastase","volume":"81","author":"Walsh","year":"1991","journal-title":"Clin Sci (Lond)"},{"key":"10.1124\/pr.115.011247_bib878","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1093\/ndt\/gft406","article-title":"Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials","volume":"28","author":"Wang","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/pr.115.011247_bib879","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/elan.200900434","article-title":"Quantitative Determination of High Charge Density Polyanion Contaminants in Biomedical Heparin Preparations Using Potentiometric Polyanion Sensors","volume":"22","author":"Wang","year":"2010","journal-title":"Electroanalysis"},{"key":"10.1124\/pr.115.011247_bib880","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/01.RES.84.1.74","article-title":"Heparin proteoglycans released from rat serosal mast cells inhibit proliferation of rat aortic smooth muscle cells in culture","volume":"84","author":"Wang","year":"1999","journal-title":"Circ Res"},{"key":"10.1124\/pr.115.011247_bib881","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2710.2006.00769.x","article-title":"Enoxaparin-induced alopecia in patients with cerebral venous thrombosis","volume":"31","author":"Wang","year":"2006","journal-title":"J Clin Pharm Ther"},{"key":"10.1124\/pr.115.011247_bib882","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1365-2141.1996.d01-1481.x","article-title":"Heparin-induced skin lesions","volume":"92","author":"Warkentin","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1124\/pr.115.011247_bib883","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/ehm.10.54","article-title":"Fondaparinux: does it cause HIT? Can it treat HIT?","volume":"3","author":"Warkentin","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1124\/pr.115.011247_bib884","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/14740330902778180","article-title":"Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes","volume":"8","author":"Warkentin","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"Suppl","key":"10.1124\/pr.115.011247_bib885","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"key":"10.1124\/pr.115.011247_bib886","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A 14-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"10.1124\/pr.115.011247_bib887","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1056\/NEJMc070346","article-title":"Heparin-induced thrombocytopenia associated with fondaparinux","volume":"356","author":"Warkentin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.115.011247_bib888","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1378\/chest.127.5.1857","article-title":"Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study","volume":"127","author":"Warkentin","year":"2005","journal-title":"Chest"},{"key":"10.1124\/pr.115.011247_bib889","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1160\/th14-08-0711","article-title":"HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux-induced HIT","volume":"112","author":"Warkentin","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib890","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1182\/blood.V82.9.2649.2649","article-title":"The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes","volume":"82","author":"Watt","year":"1993","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib891","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1099\/vir.0.037317-0","article-title":"Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding","volume":"93","author":"Watterson","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1124\/pr.115.011247_bib892","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0301-4622(88)80036-X","article-title":"Circular dichroism of isolated ricin A- and B-chains","volume":"31","author":"Wawrzynczak","year":"1988","journal-title":"Biophys Chem"},{"key":"10.1124\/pr.115.011247_bib893","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbrc.2009.01.062","article-title":"NMR structure of the Wnt modulator protein Sclerostin","volume":"380","author":"Weidauer","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.115.011247_bib894","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11239-009-0411-6","article-title":"Update on heparin: what do we need to know?","volume":"29","author":"Weitz","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"10.1124\/pr.115.011247_bib895","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri3690","article-title":"Mast cell secretory granules: armed for battle","volume":"14","author":"Wernersson","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/pr.115.011247_bib896","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1111\/febs.12187","article-title":"Neoproteoglycans in tissue engineering","volume":"280","author":"Weyers","year":"2013","journal-title":"FEBS J"},{"key":"10.1124\/pr.115.011247_bib897","doi-asserted-by":"crossref","first-page":"16420","DOI":"10.1073\/pnas.1310097110","article-title":"Structural insights into proteoglycan-shaped Hedgehog signaling","volume":"110","author":"Whalen","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib898","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archinte.158.14.1525","article-title":"Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty","volume":"158","author":"White","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1124\/pr.115.011247_bib899","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1160\/TH03-03-0152","article-title":"Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures","volume":"90","author":"White","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1124\/pr.115.011247_bib900","doi-asserted-by":"crossref","first-page":"35767","DOI":"10.1074\/jbc.M304803200","article-title":"Mechanism of catalysis of inhibition of factor IXa by antithrombin in the presence of heparin or pentasaccharide","volume":"278","author":"Wiebe","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib901","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.4049\/jimmunol.140.10.3401","article-title":"Inhibition of allergic encephalomyelitis in rats by treatment with sulfated polysaccharides","volume":"140","author":"Willenborg","year":"1988","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011247_bib902","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1053\/euhj.2001.2608","article-title":"Comparison of the heparin coated vs the uncoated Jostent--no influence on restenosis or clinical outcome","volume":"22","author":"W\u00f6hrle","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1124\/pr.115.011247_bib903","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/jvi.63.1.52-58.1989","article-title":"Initial interaction of herpes simplex virus with cells is binding to heparan sulfate","volume":"63","author":"WuDunn","year":"1989","journal-title":"J Virol"},{"key":"10.1124\/pr.115.011247_bib904","doi-asserted-by":"crossref","first-page":"12913","DOI":"10.1074\/jbc.271.22.12913","article-title":"Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa","volume":"271","author":"Wuillemin","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib905","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.4049\/jimmunol.159.4.1953","article-title":"Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma","volume":"159","author":"Wuillemin","year":"1997","journal-title":"J Immunol"},{"key":"10.1124\/pr.115.011247_bib906","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2008-04-153288","article-title":"Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion","volume":"112","author":"Xiao","year":"2008","journal-title":"Blood"},{"key":"10.1124\/pr.115.011247_bib907","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/glycob\/cwq123","article-title":"Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages","volume":"21","author":"Xiao","year":"2011","journal-title":"Glycobiology"},{"key":"10.1124\/pr.115.011247_bib908","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/sj.bjp.0701454","article-title":"Inhibitory effect of locally administered heparin on leukocyte rolling and chemoattractant-induced firm adhesion in rat mesenteric venules in vivo","volume":"122","author":"Xie","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.115.011247_bib1029","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","article-title":"Demystifying heparan sulfate-protein interactions","volume":"83","author":"Xu","year":"2014","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/pr.115.011247_bib909","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0141-8130(02)00015-6","article-title":"Effect of heparin chain length on the interaction with tissue factor pathway inhibitor (TFPI)","volume":"30","author":"Xu","year":"2002","journal-title":"Int J Biol Macromol"},{"key":"10.1124\/pr.115.011247_bib910","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1126\/science.1207478","article-title":"Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins","volume":"334","author":"Xu","year":"2011","journal-title":"Science"},{"key":"10.1124\/pr.115.011247_bib911","doi-asserted-by":"crossref","first-page":"16229","DOI":"10.1073\/pnas.1103407108","article-title":"Crystal structure of amyloid precursor-like protein 1 and heparin complex suggests a dual role of heparin in E2 dimerization","volume":"108","author":"Xue","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.115.011247_bib912","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1124\/jpet.113.211169","article-title":"Follistatin: a novel therapeutic for the improvement of muscle regeneration","volume":"349","author":"Yaden","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.115.011247_bib913","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1016\/S0021-9258(17)49632-3","article-title":"Isolation of the porcine heparin tetrasaccharides with glucuronate 2-O-sulfate. Heparinase cleaves glucuronate 2-O-sulfate-containing disaccharides in highly sulfated blocks in heparin","volume":"270","author":"Yamada","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib914","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a002493","article-title":"Shaping morphogen gradients by proteoglycans","volume":"1","author":"Yan","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1124\/pr.115.011247_bib915","first-page":"2146","article-title":"Heparin ameliorates brain injury by inhibiting leukocyte accumulation","volume":"27","author":"Yanaka","year":"1996","journal-title":"Stroke"},{"key":"10.1124\/pr.115.011247_bib916","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.carbpol.2013.06.079","article-title":"Structural characterization and antitumor activity of a pectic polysaccharide from Codonopsis pilosula","volume":"98","author":"Yang","year":"2013","journal-title":"Carbohydr Polym"},{"key":"10.1124\/pr.115.011247_bib917","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1021\/bi300353c","article-title":"Characterization of the heparin-binding site of the protein z-dependent protease inhibitor","volume":"51","author":"Yang","year":"2012","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib918","doi-asserted-by":"crossref","first-page":"28488","DOI":"10.1074\/jbc.M110.143321","article-title":"Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa","volume":"285","author":"Yang","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib919","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0049-3848(98)00017-6","article-title":"Structural requirements of human tissue factor pathway inhibitor (TFPI) and heparin for TFPI-heparin interaction","volume":"89","author":"Ye","year":"1998","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib920","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0076-6879(10)78009-5","article-title":"Applications of heparin and heparan sulfate microarrays","volume":"478","author":"Yin","year":"2010","journal-title":"Methods Enzymol"},{"key":"10.1124\/pr.115.011247_bib921","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.avsg.2012.06.010","article-title":"Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin","volume":"27","author":"Yoshida","year":"2013","journal-title":"Ann Vasc Surg"},{"key":"10.1124\/pr.115.011247_bib922","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/adhm.201300054","article-title":"Multilayered heparin hydrogel microwells for cultivation of primary hepatocytes","volume":"3","author":"You","year":"2014","journal-title":"Adv Healthc Mater"},{"key":"10.1124\/pr.115.011247_bib923","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbagen.2005.08.003","article-title":"Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance","volume":"1726","author":"Yu","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.115.011247_bib924","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.1016\/j.biomaterials.2012.07.042","article-title":"The effect of stromal cell-derived factor-1\u03b1\/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration","volume":"33","author":"Yu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1124\/pr.115.011247_bib925","doi-asserted-by":"crossref","first-page":"32200","DOI":"10.1074\/jbc.M505738200","article-title":"Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry","volume":"280","author":"Yu","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib926","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-0037-1615131","article-title":"Heparin and cancer","volume":"80","author":"Zacharski","year":"1998","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"10.1124\/pr.115.011247_bib927","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2000-9499","article-title":"Low-molecular-weight heparin and cancer","volume":"26","author":"Zacharski","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pr.115.011247_bib928","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/ndt\/gft243","article-title":"Heparin\/heparan sulphate interactions with complement--a possible target for reduction of renal function loss?","volume":"29","author":"Zaferani","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/pr.115.011247_bib929","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1074\/jbc.M110.167825","article-title":"Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease","volume":"286","author":"Zaferani","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib930","doi-asserted-by":"crossref","first-page":"31471","DOI":"10.1074\/jbc.M112.380386","article-title":"Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate","volume":"287","author":"Zaferani","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib931","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1099\/vir.0.80614-0","article-title":"Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography","volume":"86","author":"Zahn","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1124\/pr.115.011247_bib932","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/mas.20200","article-title":"On-line separations combined with MS for analysis of glycosaminoglycans","volume":"28","author":"Zaia","year":"2009","journal-title":"Mass Spectrom Rev"},{"key":"10.1124\/pr.115.011247_bib933","doi-asserted-by":"crossref","first-page":"L347","DOI":"10.1152\/ajplung.00152.2014","article-title":"Postexposure aerosolized heparin reduces lung injury in chlorine-exposed mice","volume":"307","author":"Zarogiannis","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/pr.115.011247_bib934","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0002-9440(10)62321-8","article-title":"Heparanase regulates murine hair growth","volume":"166","author":"Zcharia","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1124\/pr.115.011247_bib935","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0031-1276585","article-title":"C1-inhibitor: more than a serine protease inhibitor","volume":"37","author":"Zeerleder","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1124\/pr.115.011247_bib936","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jaci.2004.05.026","article-title":"Heparin attenuates symptoms and mast cell degranulation induced by AMP nasal provocation","volume":"114","author":"Zeng","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/pr.115.011247_bib937","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1021\/bi300804g","article-title":"Analysis of the interaction between heparin and follistatin and heparin and follistatin-ligand complexes using surface plasmon resonance","volume":"51","author":"Zhang","year":"2012","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib938","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.biochi.2011.10.015","article-title":"Biophysical characterization of glycosaminoglycan-IL-7 interactions using SPR","volume":"94","author":"Zhang","year":"2012","journal-title":"Biochimie"},{"key":"10.1124\/pr.115.011247_bib939","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1007\/s00216-011-5367-7","article-title":"Structural characterization of heparins from different commercial sources","volume":"401","author":"Zhang","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/pr.115.011247_bib940","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1386-1425(01)00530-3","article-title":"Molecular spectroscopic studies on the interaction of glycosaminoglycans with brilliant cresol blue and its analytical application","volume":"58","author":"Zhang","year":"2002","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1124\/pr.115.011247_bib941","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.thromres.2014.11.015","article-title":"Long-term treatment with low-molecular-weight heparin prolonged the survival time for acute pulmonary embolism patients concurrent with malignancy: an observational analysis from a long-term follow-up study","volume":"135","author":"Zhang","year":"2015","journal-title":"Thromb Res"},{"key":"10.1124\/pr.115.011247_bib942","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1021\/ac9001707","article-title":"Quantification of heparan sulfate disaccharides using ion-pairing reversed-phase microflow high-performance liquid chromatography with electrospray ionization trap mass spectrometry","volume":"81","author":"Zhang","year":"2009","journal-title":"Anal Chem"},{"key":"10.1124\/pr.115.011247_bib943","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-012-0997-1","article-title":"Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-\u03b2 in murine brain","volume":"124","author":"Zhang","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1124\/pr.115.011247_bib944","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1021\/bi100549y","article-title":"Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans","volume":"49","author":"Zhao","year":"2010","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib945","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.febslet.2011.06.023","article-title":"Asparagine 405 of heparin lyase II prevents the cleavage of glycosidic linkages proximate to a 3-O-sulfoglucosamine residue","volume":"585","author":"Zhao","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.115.011247_bib1030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/BSR20110077","article-title":"Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides","volume":"32","author":"Zhao","year":"2012","journal-title":"Biosci Rep"},{"key":"10.1124\/pr.115.011247_bib946","doi-asserted-by":"crossref","first-page":"14793","DOI":"10.1021\/bi9908641","article-title":"Identification and dynamics of a heparin-binding site in hepatocyte growth factor","volume":"38","author":"Zhou","year":"1999","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib947","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0969-2126(98)00012-4","article-title":"The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site","volume":"6","author":"Zhou","year":"1998","journal-title":"Structure"},{"key":"10.1124\/pr.115.011247_bib948","article-title":"Complement C1 esterase inhibitor levels linked to infections and contaminated heparin-associated adverse events","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011247_bib949","article-title":"Oversulfated chondroitin sulfate inhibits the complement classical pathway by potentiating C1 inhibitor","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/pr.115.011247_bib950","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.actbio.2014.01.022","article-title":"Fabrication of highly interconnected porous silk fibroin scaffolds for potential use as vascular grafts","volume":"10","author":"Zhu","year":"2014","journal-title":"Acta Biomater"},{"key":"10.1124\/pr.115.011247_bib951","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1021\/bi101596g","article-title":"Elucidation of inositol hexaphosphate and heparin interaction sites and conformational changes in arrestin-1 by solution nuclear magnetic resonance","volume":"49","author":"Zhuang","year":"2010","journal-title":"Biochemistry"},{"key":"10.1124\/pr.115.011247_bib952","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1074\/jbc.M112.394064","article-title":"Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus","volume":"288","author":"Ziarek","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.115.011247_bib953","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0092-8674(00)80133-6","article-title":"The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4","volume":"86","author":"Zimmerman","year":"1996","journal-title":"Cell"},{"key":"10.1124\/pr.115.011247_bib954","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.matbio.2009.04.010","article-title":"Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis","volume":"28","author":"Zoeller","year":"2009","journal-title":"Matrix Biol"},{"key":"10.1124\/pr.115.011247_bib955","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3181\/00379727-198-43309","article-title":"Platelet factor 4: production, structure, and physiologic and immunologic action","volume":"198","author":"Zucker","year":"1991","journal-title":"Proc Soc Exp Biol Med"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724011712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724011712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pr.115.011247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T10:47:52Z","timestamp":1739875672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724011712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":998,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0031699724011712"],"URL":"https:\/\/doi.org\/10.1124\/pr.115.011247","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacology of Heparin and Related Drugs","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pr.115.011247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}